

<!DOCTYPE html>
<html lang="en" class="no-js">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta name="applicable-device" content="pc,mobile">
    <meta name="access" content="Yes">

    

    <meta name="twitter:site" content="@SpringerLink"/>

    <meta name="twitter:card" content="summary"/>

    <meta name="twitter:image:alt" content="Content cover image"/>

    <meta name="twitter:title" content="Neurovaskuläre Manifestationen von COVID‑19"/>

    <meta name="twitter:description" content="Der Nervenarzt - Bereits fr&#252;h nach Beginn der COVID&#8209;19(&#8222;coronavirus disease 2019&#8220;)-Pandemie wurden Schlaganf&#228;lle als Manifestation oder Komplikation einer..."/>

    <meta name="twitter:image" content="https://static-content.springer.com/cover/journal/115/92/6.jpg"/>

    <meta name="journal_id" content="115"/>

    <meta name="dc.title" content="Neurovaskul&#228;re Manifestationen von COVID&#8209;19"/>

    <meta name="dc.source" content="Der Nervenarzt 2021 92:6"/>

    <meta name="dc.format" content="text/html"/>

    <meta name="dc.publisher" content="Springer"/>

    <meta name="dc.date" content="2021-03-24"/>

    <meta name="dc.type" content="ReviewPaper"/>

    <meta name="dc.language" content="De"/>

    <meta name="dc.copyright" content="2021 The Author(s)"/>

    <meta name="dc.rightsAgent" content="journalpermissions@springernature.com"/>

    <meta name="dc.description" content="Bereits fr&#252;h nach Beginn der COVID&#8209;19(&#8222;coronavirus disease 2019&#8220;)-Pandemie wurden Schlaganf&#228;lle als Manifestation oder Komplikation einer SARS-CoV-2(&#8222;severe acute respiratory syndrome coronavirus&#160;2&#8220;)-Infektion beschrieben. Aktuelle Metaanalysen berichten eine Schlaganfallrate von etwa 1,5&#8239;%. Schlaganf&#228;lle bei COVID&#8209;19-Patienten treten zwar h&#228;ufiger bei schweren Verl&#228;ufen der Infektion und bei &#228;lteren Patienten mit kardiovaskul&#228;ren Risiken auf. Nicht selten sind aber auch junge Patienten ohne Risikofaktoren betroffen. Die Schlaganfallmechanismen sind vorwiegend embolisch, die Thromben verschlie&#223;en h&#228;ufig gro&#223;e intrakranielle Gef&#228;&#223;e und betreffen in mehr als 20&#8239;% mehrere Gef&#228;&#223;territorien, w&#228;hrend mikroangiopathische Infarkte selten sind. Die genaue Emboliequelle bleibt bei &#252;ber 40&#8239;% der Betroffenen kryptogen. Die durch das Zusammentreffen einer SARS-CoV-2-Infektion und eines Schlaganfalls bedingte Mortalit&#228;t betr&#228;gt mehr als 15&#8211;30&#8239;%. W&#228;hrend es in manchen europ&#228;ischen Regionen zu erheblichen Einschr&#228;nkungen der Akutversorgung von Schlaganf&#228;llen gekommen ist, sind die Behandlungsraten f&#252;r die Rekanalisationstherapie in Deutschland w&#228;hrend der 1.&#160;Pandemiewelle weitgehend stabil geblieben. Es stellten sich aber 20&#8211;30&#8239;% weniger Patienten mit v.&#8239;a. leichteren Schlaganf&#228;llen und transitorischen isch&#228;mischen Attacken in Krankenh&#228;usern vor. Die vorliegende &#220;bersichtsarbeit fasst die aktuellen Erkenntnisse zur Epidemiologie und Pathogenese COVID&#8209;19-assoziierter Schlaganf&#228;lle zusammen und beschreibt die bisherigen Auswirkungen der Pandemie auf die Schlaganfallakutversorgung."/>

    <meta name="prism.issn" content="1433-0407"/>

    <meta name="prism.publicationName" content="Der Nervenarzt"/>

    <meta name="prism.publicationDate" content="2021-03-24"/>

    <meta name="prism.volume" content="92"/>

    <meta name="prism.number" content="6"/>

    <meta name="prism.section" content="ReviewPaper"/>

    <meta name="prism.startingPage" content="531"/>

    <meta name="prism.endingPage" content="539"/>

    <meta name="prism.copyright" content="2021 The Author(s)"/>

    <meta name="prism.rightsAgent" content="journalpermissions@springernature.com"/>

    <meta name="prism.url" content="https://link.springer.com/article/10.1007/s00115-021-01104-1"/>

    <meta name="prism.doi" content="doi:10.1007/s00115-021-01104-1"/>

    <meta name="citation_pdf_url" content="https://link.springer.com/content/pdf/10.1007/s00115-021-01104-1.pdf"/>

    <meta name="citation_fulltext_html_url" content="https://link.springer.com/article/10.1007/s00115-021-01104-1"/>

    <meta name="citation_journal_title" content="Der Nervenarzt"/>

    <meta name="citation_journal_abbrev" content="Nervenarzt"/>

    <meta name="citation_publisher" content="Springer Medizin"/>

    <meta name="citation_issn" content="1433-0407"/>

    <meta name="citation_title" content="Neurovaskul&#228;re Manifestationen von COVID&#8209;19"/>

    <meta name="citation_volume" content="92"/>

    <meta name="citation_issue" content="6"/>

    <meta name="citation_publication_date" content="2021/06"/>

    <meta name="citation_online_date" content="2021/03/24"/>

    <meta name="citation_firstpage" content="531"/>

    <meta name="citation_lastpage" content="539"/>

    <meta name="citation_article_type" content="Leitthema"/>

    <meta name="citation_fulltext_world_readable" content=""/>

    <meta name="citation_language" content="de"/>

    <meta name="dc.identifier" content="doi:10.1007/s00115-021-01104-1"/>

    <meta name="DOI" content="10.1007/s00115-021-01104-1"/>

    <meta name="citation_doi" content="10.1007/s00115-021-01104-1"/>

    <meta name="description" content="Bereits fr&#252;h nach Beginn der COVID&#8209;19(&#8222;coronavirus disease 2019&#8220;)-Pandemie wurden Schlaganf&#228;lle als Manifestation oder Komplika"/>

    <meta name="dc.creator" content="Veltkamp, Roland"/>

    <meta name="dc.creator" content="Purrucker, Jan C."/>

    <meta name="dc.creator" content="Weber, Ralph"/>

    <meta name="dc.subject" content="Neurology"/>

    <meta name="dc.subject" content="Psychiatry"/>

    <meta name="dc.subject" content="Psychosomatic Medicine"/>

    <meta name="dc.subject" content="Psychotherapy"/>

    <meta name="dc.subject" content="Psychopharmacology"/>

    <meta name="dc.subject" content="Neurosurgery"/>

    <meta name="citation_reference" content="citation_journal_title=Eur Stroke J; citation_title=Maintaining stroke care in Europe during the COVID&#8209;19 pandemic: Results from an international survey of stroke professionals and practice recommendations from the European Stroke Organisation; citation_author=D Aguiar De Sousa, HB Der Worp, V Caso; citation_volume=5; citation_publication_date=2020; citation_pages=230-236; citation_doi=10.1177/2396987320933746; citation_id=CR1"/>

    <meta name="citation_reference" content="Baldini T, Asioli GM, Romoli M et al (2021) Cerebral venous thrombosis and severe acute respiratory syndrome coronavirus&#8209;2 infection: a systematic review and meta-analysis. Eur J Neurol. 
                  https://doi.org/10.1111/ene.14727
                  
                "/>

    <meta name="citation_reference" content="citation_journal_title=Stroke; citation_title=Ischemic stroke occurs less frequently in patients with COVID&#8209;19: a multicenter cross-sectional study; citation_author=K Bekelis, S Missios, J Ahmad; citation_volume=51; citation_publication_date=2020; citation_pages=3570-3576; citation_doi=10.1161/STROKEAHA.120.031217; citation_id=CR3"/>

    <meta name="citation_reference" content="citation_journal_title=Eur J Neurol; citation_title=Stroke care during the COVID&#8209;19 pandemic: experience from three large European countries; citation_author=A Bersano, M Kraemer, E Touze; citation_volume=27; citation_publication_date=2020; citation_pages=1794-1800; citation_doi=10.1111/ene.14375; citation_id=CR4"/>

    <meta name="citation_reference" content="citation_journal_title=Ann Clin Transl Neurol; citation_title=Influenza-like illness as a&#160;trigger for ischemic stroke; citation_author=AK Boehme, J Luna, ER Kulick; citation_volume=5; citation_publication_date=2018; citation_pages=456-463; citation_doi=10.1002/acn3.545; citation_id=CR5"/>

    <meta name="citation_reference" content="citation_journal_title=Circulation; citation_title=Effect of COVID&#8209;19 on first-time acute stroke and transient ischemic attack admission rates and prognosis in Denmark: a nationwide cohort study; citation_author=JH Butt, EL Fosbol, L Ostergaard; citation_volume=142; citation_publication_date=2020; citation_pages=1227-1229; citation_doi=10.1161/CIRCULATIONAHA.120.050173; citation_id=CR6"/>

    <meta name="citation_reference" content="citation_journal_title=Heart; citation_title=COVID&#8209;19 and acute myocardial injury: the heart of the matter or an innocent bystander?; citation_author=R Cheng, D Leedy; citation_volume=106; citation_publication_date=2020; citation_pages=1122-1124; citation_doi=10.1136/heartjnl-2020-317025; citation_id=CR7"/>

    <meta name="citation_reference" content="citation_journal_title=Neuroepidemiology; citation_title=Relationship between supra-annual trends in influenza rates and stroke occurrence; citation_author=TS Field, H Zhu, M Tarrant; citation_volume=23; citation_publication_date=2004; citation_pages=228-235; citation_doi=10.1159/000079948; citation_id=CR8"/>

    <meta name="citation_reference" content="citation_journal_title=Neurology; citation_title=Stroke risk, phenotypes, and death in COVID&#8209;19: systematic review and newly reported cases; citation_author=S Fridman, M Bres Bullrich, A Jimenez-Ruiz; citation_volume=95; citation_publication_date=2020; citation_pages=e3373-e3385; citation_doi=10.1212/WNL.0000000000010851; citation_id=CR9"/>

    <meta name="citation_reference" content="citation_journal_title=Transl Stroke Res; citation_title=COVID&#8209;19-related stroke; citation_author=DC Hess, W Eldahshan, E Rutkowski; citation_volume=11; citation_publication_date=2020; citation_pages=322-325; citation_doi=10.1007/s12975-020-00818-9; citation_id=CR10"/>

    <meta name="citation_reference" content="citation_journal_title=Lancet; citation_title=Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China; citation_author=C Huang, Y Wang, X Li; citation_volume=395; citation_publication_date=2020; citation_pages=497-506; citation_doi=10.1016/S0140-6736(20)30183-5; citation_id=CR11"/>

    <meta name="citation_reference" content="citation_journal_title=J Thromb Haemost; citation_title=Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation; citation_author=T Iba, JH Levy, TE Warkentin; citation_volume=17; citation_publication_date=2019; citation_pages=1989-1994; citation_doi=10.1111/jth.14578; citation_id=CR12"/>

    <meta name="citation_reference" content="citation_journal_title=J Stroke Cerebrovasc Dis; citation_title=Impact of the Coronavirus disease pandemic on the number of strokes and mechanical thrombectomies: a systematic review and meta-analysis; citation_author=J July, R Pranata; citation_volume=29; citation_publication_date=2020; citation_pages=105185; citation_doi=10.1016/j.jstrokecerebrovasdis.2020.105185; citation_id=CR13"/>

    <meta name="citation_reference" content="citation_journal_title=Stroke; citation_title=Mechanical thrombectomy for acute ischemic stroke amid the COVID&#8209;19 outbreak: decreased activity, and increased care delays; citation_author=B Kerleroux, T Fabacher, N Bricout; citation_volume=51; citation_publication_date=2020; citation_pages=2012-2017; citation_doi=10.1161/STROKEAHA.120.030373; citation_id=CR14"/>

    <meta name="citation_reference" content="citation_journal_title=Neurology; citation_title=Influenza vaccination and cardiovascular risk in patients with recent TIA and stroke; citation_author=PC Lavallee, J Labreuche, KM Fox; citation_volume=82; citation_publication_date=2014; citation_pages=1905-1913; citation_doi=10.1212/WNL.0000000000000456; citation_id=CR15"/>

    <meta name="citation_reference" content="citation_journal_title=Neuroepidemiology; citation_title=Effect of influenza vaccination on risk of stroke: a systematic review and meta-analysis; citation_author=KR Lee, JH Bae, IC Hwang; citation_volume=48; citation_publication_date=2017; citation_pages=103-110; citation_doi=10.1159/000478017; citation_id=CR16"/>

    <meta name="citation_reference" content="citation_journal_title=Stroke Vasc Neurol; citation_title=Acute cerebrovascular disease following COVID&#8209;19: a&#160;single center, retrospective, observational study; citation_author=Y Li, M Li, M Wang; citation_volume=5; citation_publication_date=2020; citation_pages=279-284; citation_doi=10.1136/svn-2020-000431; citation_id=CR17"/>

    <meta name="citation_reference" content="Marchandot B, Sattler L, Jesel L et al (2020) COVID&#8209;19 related Coagulopathy: a distinct entity? J&#160;Clin Med 31:1651"/>

    <meta name="citation_reference" content="Merkler AE, Parikh NS, Mir S et al (2020) Risk of Ischemic stroke in patients with Coronavirus disease 2019 (COVID&#8209;19) vs patients with influenza. JAMA Neurol 77:1&#8211;7"/>

    <meta name="citation_reference" content="Millan M, Nagel S, Gumbinger C et al (2020) Differential effects of the SARS-CoV&#8209;2 pandemic on patients presenting to a&#160;neurological emergency room depending on their triage score in an area with low COVID&#8209;19 incidence. Eur J Neurol. 
                  https://doi.org/10.1111/ene.14709
                  
                "/>

    <meta name="citation_reference" content="citation_journal_title=Circulation; citation_title=Acute COVID&#8209;19 and the incidence of Ischemic stroke and acute myocardial infarction; citation_author=D Modin, B Claggett, C Sindet-Pedersen; citation_volume=142; citation_publication_date=2020; citation_pages=2080-2082; citation_doi=10.1161/CIRCULATIONAHA.120.050809; citation_id=CR21"/>

    <meta name="citation_reference" content="citation_journal_title=Int J Stroke; citation_title=Stroke in COVID&#8209;19: a systematic review and meta-analysis; citation_author=S Nannoni, R Groot, S Bell; citation_volume=16; citation_publication_date=2021; citation_pages=137-149; citation_doi=10.1177/1747493020972922; citation_id=CR22"/>

    <meta name="citation_reference" content="citation_journal_title=N Engl J Med; citation_title=Large-vessel stroke as a&#160;presenting feature of Covid-19 in the young; citation_author=TJ Oxley, J Mocco, S Majidi; citation_volume=382; citation_publication_date=2020; citation_pages=e60; citation_doi=10.1056/NEJMc2009787; citation_id=CR23"/>

    <meta name="citation_reference" content="Perry RJ, Smith CJ, Roffe C et al (2020) Characteristics and outcomes of COVID&#8209;19 associated stroke: a&#160;UK multicentre case-control study. J&#160;Neurol Neurosurg Psychiatry 92:242&#8211;248"/>

    <meta name="citation_reference" content="citation_journal_title=N Engl J Med; citation_title=Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine; citation_author=FP Polack, SJ Thomas, N Kitchin; citation_volume=383; citation_publication_date=2020; citation_pages=2603-2615; citation_doi=10.1056/NEJMoa2034577; citation_id=CR25"/>

    <meta name="citation_reference" content="Qureshi AI, Baskett WI, Huang W et al (2021) Acute Ischemic stroke and COVID&#8209;19: an analysis of 27 676 patients. Stroke. 
                  https://doi.org/10.1161/STROKEAHA.120.031786
                  
                "/>

    <meta name="citation_reference" content="citation_journal_title=Neurol Res Pract; citation_title=Letter to the editor: risk comorbidities of COVID&#8209;19 in Parkinson&#8242;s disease patients in Germany; citation_author=D Richter, D Bartig, C Krogias; citation_volume=2; citation_publication_date=2020; citation_pages=22; citation_doi=10.1186/s42466-020-00069-x; citation_id=CR27"/>

    <meta name="citation_reference" content="citation_journal_title=Neurol Res Pract; citation_title=Comparison of stroke care parameters in acute ischemic stroke patients with and without concurrent Covid-19. A Nationwide analysis; citation_author=D Richter, C Krogias, J Eyding; citation_volume=2; citation_publication_date=2020; citation_pages=48; citation_doi=10.1186/s42466-020-00095-9; citation_id=CR28"/>

    <meta name="citation_reference" content="Schlachetzki F, Theek C, Hubert ND et al (2020) Low stroke incidence in the TEMPiS telestroke network during COVID&#8209;19 pandemic &#8211; effect of lockdown on thrombolysis and thrombectomy. J&#160;Telemed Telecare. 
                  https://doi.org/10.1177/1357633X20943327
                  
                "/>

    <meta name="citation_reference" content="citation_journal_title=Clin Res Cardiol; citation_title=Temporal trends in the presentation of cardiovascular and cerebrovascular emergencies during the COVID&#8209;19 pandemic in Germany: an analysis of health insurance claims; citation_author=M Seiffert, FJ Brunner, M Remmel; citation_volume=109; citation_publication_date=2020; citation_pages=1540-1548; citation_doi=10.1007/s00392-020-01723-9; citation_id=CR30"/>

    <meta name="citation_reference" content="citation_journal_title=Int J Stroke; citation_title=Preceding infection and risk of stroke: an old concept revived by the COVID&#8209;19 pandemic; citation_author=K South, L Mcculloch, BW Mccoll; citation_volume=15; citation_publication_date=2020; citation_pages=722-732; citation_doi=10.1177/1747493020943815; citation_id=CR31"/>

    <meta name="citation_reference" content="citation_journal_title=Eur J Neurol; citation_title=Impact of COVID&#8209;19 outbreak in reperfusion therapies of acute ischaemic stroke in northwest Spain; citation_author=H Tejada Meza, GA Lambea, SA Saldana; citation_volume=27; citation_publication_date=2020; citation_pages=2491-2498; citation_doi=10.1111/ene.14467; citation_id=CR32"/>

    <meta name="citation_reference" content="citation_journal_title=Age Ageing; citation_title=Temporal relationship between influenza infections and subsequent first-ever stroke incidence; citation_author=AM Toschke, PU Heuschmann, O Wood; citation_volume=38; citation_publication_date=2009; citation_pages=100-103; citation_doi=10.1093/ageing/afn232; citation_id=CR33"/>

    <meta name="citation_reference" content="citation_journal_title=Ther Adv Neurol Disord; citation_title=COVID&#8209;19 and cerebrovascular diseases: a&#160;comprehensive overview; citation_author=G Tsivgoulis, L Palaiodimou, R Zand; citation_volume=13; citation_publication_date=2020; citation_pages=1756286420978004; citation_id=CR34"/>

    <meta name="citation_reference" content="citation_journal_title=JAMA; citation_title=Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a&#160;meta-analysis; citation_author=JA Udell, R Zawi, DL Bhatt; citation_volume=310; citation_publication_date=2013; citation_pages=1711-1720; citation_doi=10.1001/jama.2013.279206; citation_id=CR35"/>

    <meta name="citation_reference" content="citation_journal_title=Lancet; citation_title=Endothelial cell infection and endotheliitis in COVID&#8209;19; citation_author=Z Varga, AJ Flammer, P Steiger; citation_volume=395; citation_publication_date=2020; citation_pages=1417-1418; citation_doi=10.1016/S0140-6736(20)30937-5; citation_id=CR36"/>

    <meta name="citation_reference" content="Warren-Gash C, Blackburn R, Whitaker H et al (2018) Laboratory-confirmed respiratory infections as triggers for acute myocardial infarction and stroke: a&#160;self-controlled case series analysis of national linked datasets from Scotland. Eur Respir&#160;J. 
                  https://doi.org/10.1183/13993003.01794-2017
                  
                "/>

    <meta name="citation_reference" content="citation_journal_title=N Engl J Med; citation_title=Coagulopathy and antiphospholipid antibodies in patients with Covid-19; citation_author=Y Zhang, M Xiao, S Zhang; citation_volume=382; citation_publication_date=2020; citation_pages=e38; citation_doi=10.1056/NEJMc2007575; citation_id=CR38"/>

    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=A pneumonia outbreak associated with a&#160;new coronavirus of probable bat origin; citation_author=P Zhou, XL Yang, XG Wang; citation_volume=579; citation_publication_date=2020; citation_pages=270-273; citation_doi=10.1038/s41586-020-2012-7; citation_id=CR39"/>

    <meta name="citation_author" content="Veltkamp, Roland"/>

    <meta name="citation_author_email" content="roland.veltkamp@krupp-krankenhaus.de"/>

    <meta name="citation_author_institution" content="Neurologische Klinik, Alfried Krupp Krankenhaus Essen, Essen, Deutschland"/>

    <meta name="citation_author_institution" content="Department of Brain Sciences, Imperial College London, London, Gro&#223;britannien"/>

    <meta name="citation_author_institution" content="Neurologische Klinik, Universit&#228;tsklinikum Heidelberg, Heidelberg, Deutschland"/>

    <meta name="citation_author" content="Purrucker, Jan C."/>

    <meta name="citation_author_institution" content="Neurologische Klinik, Universit&#228;tsklinikum Heidelberg, Heidelberg, Deutschland"/>

    <meta name="citation_author" content="Weber, Ralph"/>

    <meta name="citation_author_institution" content="Neurologische Klinik, Alfried Krupp Krankenhaus Essen, Essen, Deutschland"/>

    <meta name="citation_springer_api_url" content="http://api.springer.com/metadata/pam?q=doi:10.1007/s00115-021-01104-1&amp;api_key="/>

    <meta name="format-detection" content="telephone=no"/>

    <meta name="citation_cover_date" content="2021/06/01"/>


    
        <meta property="og:url" content="https://link.springer.com/article/10.1007/s00115-021-01104-1"/>
        <meta property="og:type" content="article"/>
        <meta property="og:site_name" content="Der Nervenarzt"/>
        <meta property="og:title" content="Neurovaskuläre Manifestationen von COVID‑19 - Der Nervenarzt"/>
        <meta property="og:description" content="Even early at the beginning of the coronavirus disease 2019 (COVID‑19) pandemic, stroke was described as a manifestation or complication of infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Current meta-analyses reported a stroke rate of approximately 1.5%. Stroke in COVID‑19 positive patients occurs more frequently in severe courses of the infection and in older patients with cardiovascular comorbidities; however, young patients without cardiovascular risk factors are also not uncommonly affected. The mechanisms of stroke are predominantly embolic. The thrombi frequently occlude large intracranial vessels and in more than 20% affect multiple vascular territories, whereas infarctions due to small vessel disease are uncommon. The exact source of the embolism remains cryptogenic in more than 40% of patients. The mortality caused by the co-occurrence of a SARS-CoV‑2 infection and a stroke exceeds 15–30%. While acute stroke treatment was severely affected in some European regions, the rates of recanalization treatment in Germany largely remained stable during the first pandemic wave; however, 20–30% fewer patients with minor stroke and transient ischemic attacks (TIA) presented to hospitals during the first wave in spring 2020. The present narrative review summarizes the current evidence regarding the epidemiology and pathogenesis of stroke associated with COVID‑19 and describes the effect of the pandemic so far on the provision of acute stroke treatment."/>
        <meta property="og:image" content="https://media.springernature.com/w200/springer-static/cover/journal/115.jpg"/>
    

    <title>Neurovaskuläre Manifestationen von COVID‑19 | SpringerLink</title>

    <link rel="shortcut icon" href=/oscar-static/images/favicons/springerlink/favicon-eb9f5576a3.ico />
<link rel="icon" sizes="16x16 32x32 48x48" href=/oscar-static/images/favicons/springerlink/favicon-eb9f5576a3.ico />
<link rel="icon" sizes="16x16" type="image/png" href=/oscar-static/images/favicons/springerlink/favicon-16x16-8bd8c1c945.png />
<link rel="icon" sizes="32x32" type="image/png" href=/oscar-static/images/favicons/springerlink/favicon-32x32-61a52d80ab.png />
<link rel="icon" sizes="48x48" type="image/png" href=/oscar-static/images/favicons/springerlink/favicon-48x48-0ec46b6b10.png />
<link rel="apple-touch-icon" href=/oscar-static/images/favicons/springerlink/app-icon-iphone@3x-f259d46347.png />
<link rel="apple-touch-icon" sizes="72x72" href=/oscar-static/images/favicons/springerlink/ic_launcher_hdpi-f77cda7f65.png />
<link rel="apple-touch-icon" sizes="76x76" href=/oscar-static/images/favicons/springerlink/app-icon-ipad-c3fd26520d.png />
<link rel="apple-touch-icon" sizes="114x114" href=/oscar-static/images/favicons/springerlink/app-icon-114x114-3d7d4cf9f3.png />
<link rel="apple-touch-icon" sizes="120x120" href=/oscar-static/images/favicons/springerlink/app-icon-iphone@2x-67b35150b3.png />
<link rel="apple-touch-icon" sizes="144x144" href=/oscar-static/images/favicons/springerlink/ic_launcher_xxhdpi-986442de7b.png />
<link rel="apple-touch-icon" sizes="152x152" href=/oscar-static/images/favicons/springerlink/app-icon-ipad@2x-677ba24d04.png />
<link rel="apple-touch-icon" sizes="180x180" href=/oscar-static/images/favicons/springerlink/app-icon-iphone@3x-f259d46347.png />


    
    <script>(function(H){H.className=H.className.replace(/\bno-js\b/,'js')})(document.documentElement)</script>

    <style>h1,h2{font-family:Georgia,Palatino,serif;font-style:normal}h1{margin-bottom:1em}.u-h3,h2,h3{margin-bottom:1em}.u-h3{line-height:1.4}.u-h3,h3,h4{font-family:Georgia,Palatino,serif;font-style:normal}h4{margin-bottom:1em}button{line-height:inherit}[tabindex="0"]:focus{outline:4px solid #fc0}html,label{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}html{-webkit-font-smoothing:subpixel-antialiased;box-sizing:border-box;color:#333;font-size:62.5%;height:100%;line-height:1.61803;overflow-y:scroll}*{box-sizing:inherit}body{background:#fcfcfc;max-width:100%;min-height:100%}body,figure{margin:0}button,div,form,input{margin:0;padding:0}body,p{padding:0}a{color:#004b83;text-decoration:underline;text-decoration-skip-ink:auto}a:focus{outline:4px solid #fc0}a>img{vertical-align:middle}h1,h2,h3,h4{line-height:1.4}p{margin:0}h1,h2,h3,h4,ul{margin-top:0}p{margin-bottom:1.5em}p:empty{display:none}.c-ad{text-align:center}@media only screen and (min-width:320px){.c-ad{padding:8px}}.c-ad--728x90{background-color:#ccc;display:none}.c-ad--728x90 .c-ad__inner{min-height:calc(1.5em + 94px)}@media only screen and (min-width:768px){.js .c-ad--728x90{display:none}.js .u-show-following-ad+.c-ad--728x90{display:block}}.c-ad--300x250{background-color:#f2f2f2;display:none;padding:8px}.c-ad--300x250 .c-ad__inner{min-height:calc(1.5em + 254px)}@media only screen and (min-width:320px){.js .c-ad--300x250{display:block}}.c-ad__label,.c-header{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}.c-ad__label{color:#333;font-size:1.4rem;font-weight:400;line-height:1.5;margin-bottom:4px}.c-header{background-color:#fff;border-bottom:4px solid #00285a;font-size:16px;padding:16px 0}.c-header__container{-webkit-box-align:center;-webkit-box-pack:justify;align-items:center;display:flex;justify-content:space-between;margin:0 auto;max-width:1280px;padding:0 16px}.c-header__brand{margin-right:32px}.c-header__brand a{text-decoration:none}.c-header__menu,.c-header__navigation{display:flex}.c-header__navigation{-webkit-box-align:center;align-items:center}.c-header__menu{list-style:none;margin:0;padding:0}.c-header__item{color:inherit;margin-right:24px}.c-header__item:last-child{margin-right:0}.c-header__link{color:inherit;text-decoration:none}.c-skip-link{background:#f7fbfe;color:#004b83;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1.4rem;padding:8px;position:absolute;text-align:center;transform:translateY(-100%);width:100%;z-index:9999}@media (prefers-reduced-motion:reduce){.c-skip-link{transition:top .3s ease-in-out 0s}}@media print{.c-skip-link{display:none}}.c-skip-link:link{color:#004b83}h1{font-size:3.2rem}.u-h3,h1,h2,h3{font-weight:700}.u-h3,h2,h3{font-size:2.8rem}.u-h3,h3{font-size:2.4rem}h4{font-size:2rem;font-weight:700}body{font-size:1.8em}.c-article-header{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;margin-bottom:40px}.c-article-main-column{font-family:Georgia,Palatino,serif;margin-right:8.6%;width:60.2%}@media only screen and (max-width:1023px){.c-article-main-column{margin-right:0;width:100%}}.c-article__sub-heading{color:#222;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:2rem;font-style:normal;font-weight:400;line-height:1.3;margin:0 0 8px}@media only screen and (min-width:768px){.c-article__sub-heading{font-size:2.4rem;line-height:1.24}}.c-article-extras{float:left;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;width:31.2%}@media only screen and (max-width:1023px){.c-article-extras{display:none}}.c-pdf-download{display:flex;margin-bottom:24px;max-height:48px}@media only screen and (min-width:540px){.c-pdf-download{max-height:none}}@media only screen and (min-width:1024px){.c-pdf-download{max-height:48px}}.c-pdf-download__link{-webkit-box-pack:justify;-webkit-box-flex:1;background:linear-gradient(#4d78af,#3365a0);border:1px solid transparent;border-radius:2px;color:#fff;display:flex;flex:1 1 0%;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1.6rem;justify-content:space-between;line-height:1.3;padding:13px 24px;text-decoration:none}.c-popup-search{background-color:#eee;box-shadow:0 3px 3px -3px rgba(0,0,0,.21);padding:16px 0;position:relative;z-index:10}@media only screen and (min-width:1024px){.js .c-popup-search{position:absolute;top:100%;width:100%}.c-popup-search__container{margin:auto;max-width:70%}}.app-search__content{display:flex}.app-search__label{color:#666;display:inline-block;font-size:1.4rem;margin-bottom:8px}.app-search__input{-webkit-box-flex:0;border:1px solid #b3b3b3;border-bottom-left-radius:3px;border-top-left-radius:3px;box-shadow:inset 0 1px 3px 0 rgba(0,0,0,.21);flex:0 1 auto;font-size:1.4rem;line-height:1.2;padding:.75em 1em;vertical-align:middle;width:100%}.app-search__button{-webkit-box-align:center;-webkit-box-pack:center;align-items:center;background-color:#33629d;background-image:linear-gradient(#4d76a9,#33629d);border:1px solid rgba(0,59,132,.5);border-radius:0 2px 2px 0;color:#fff;cursor:pointer;display:inline-flex;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:16px;justify-content:center;line-height:1.3;margin:0;padding:8px;position:relative;text-align:center;text-decoration:none;transition:all .25s ease 0s,color .25s ease 0s,border-color .25s ease 0s;width:50px}.app-search__button svg{fill:currentcolor}.u-display-block{display:block}.u-display-flex{display:flex;width:100%}.u-align-items-center{-webkit-box-align:center;align-items:center}.u-flex-static{-webkit-box-flex:0;flex:0 1 auto;flex:0 0 auto}.js .u-js-hide{display:none;visibility:hidden}@media print{.u-hide-print{display:none}}.u-icon{fill:currentcolor;display:inline-block;transform:translate(0);vertical-align:text-top}.u-button-reset{background-color:transparent;border:0;padding:0}.u-sans-serif{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}.u-container{margin:0 auto;max-width:1280px;padding:0 16px}.u-position-relative{position:relative}.u-mt-16{margin-top:16px}.u-mt-32{margin-top:32px}.u-mr-24{margin-right:24px}.u-mb-16{margin-bottom:16px}.u-mb-24{margin-bottom:24px}.u-mb-32{margin-bottom:32px}.u-ml-8{margin-left:8px}.u-hide{display:none;visibility:hidden}.u-visually-hidden{clip:rect(0,0,0,0);border:0;height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}.hide{display:none;visibility:hidden}</style>



    <link rel="stylesheet" href=/oscar-static/app-springerlink/css/core-article-633a14941d.css media="screen">
    <link rel="stylesheet" data-inline-css-source="critical-css" href="/oscar-static/app-springerlink/css/enhanced-article-5a914ae533.css" media="print" onload="this.media='only screen and (-webkit-min-device-pixel-ratio:0) and (min-color-index:0), (-ms-high-contrast: none), only all and (min--moz-device-pixel-ratio:0) and (min-resolution: 3e1dpcm)';this.onload=null">
    

    
    <script type="text/javascript">
        window.dataLayer = [{"GA Key":"UA-26408784-1","DOI":"10.1007/s00115-021-01104-1","Page":"article","page":{"attributes":{"environment":"live"}},"Country":"DE","doi":"10.1007-s00115-021-01104-1","Journal Title":"Der Nervenarzt","Journal Id":115,"Keywords":"SARS-CoV‑2, Zerebrale Ischämie, Intrazerebrale Blutung, Thrombolyse, Thrombektomie, SARS-CoV‑2, Cerebral ischemia, Intracerebral hemorrhage, Thrombolysis, Thrombectomy","kwrd":["SARS-CoV‑2","Zerebrale_Ischämie","Intrazerebrale_Blutung","Thrombolyse","Thrombektomie","SARS-CoV‑2","Cerebral_ischemia","Intracerebral_hemorrhage","Thrombolysis","Thrombectomy"],"Labs":"Y","ksg":"Krux.segments","kuid":"Krux.uid","Has Body":"Y","Features":[],"Open Access":"Y","hasAccess":"Y","bypassPaywall":"N","user":{"license":{"businessPartnerID":[],"businessPartnerIDString":""}},"Access Type":"open","Bpids":"","Bpnames":"","BPID":["1"],"VG Wort Identifier":"vgzm.415900-10.1007-s00115-021-01104-1","Full HTML":"Y","Subject Codes":["SCH","SCH36001","SCH53003","SCH75000","SCH5400X","SCH53010","SCH39000"],"pmc":["H","H36001","H53003","H75000","H5400X","H53010","H39000"],"session":{"authentication":{"loginStatus":"N"},"attributes":{"edition":"academic"}},"content":{"serial":{"eissn":"1433-0407","pissn":"0028-2804"},"type":"Article","category":{"pmc":{"primarySubject":"Medicine \u0026 Public Health","primarySubjectCode":"H","secondarySubjects":{"1":"Neurology","2":"Psychiatry","3":"Psychosomatic Medicine","4":"Psychotherapy","5":"Psychopharmacology","6":"Neurosurgery"},"secondarySubjectCodes":{"1":"H36001","2":"H53003","3":"H75000","4":"H5400X","5":"H53010","6":"H39000"}},"sucode":"SC11"},"attributes":{"deliveryPlatform":"oscar"}},"Event Category":"Article"}];
    </script>

    

    
        
    
        
            <script src=/oscar-static/js/jquery-220afd743d.js></script>
        
    

    <script data-test="onetrust-control">
        
            (function(w,d,t) {
                var assetPath = '/oscar-static/js/cookie-consent-es5-bundle-a0eb3ebbaa.js';
                function cc() {
                    var h = w.location.hostname,
                        e = d.createElement(t),
                        s = d.getElementsByTagName(t)[0];

                    if (h === "link.springer.com") {
                        e.src = "https://cdn.cookielaw.org/scripttemplates/otSDKStub.js";
                        e.setAttribute("data-domain-script", "4f53bc14-4ee3-45bd-9935-e3d2b6b2a543");
                    } else {
                        e.src = assetPath;
                        e.setAttribute("data-consent", h);
                    }
                    s.parentNode.insertBefore(e, s);
                }
                w.google_tag_manager ? cc() : window.addEventListener("gtm_loaded", cc);
            })(window,document,"script");
        
    </script>
    <script>
        function OptanonWrapper() {
            var elementInside = function(candidate, element) {
                if (candidate === element) {
                    return true;
                } else if (candidate.nodeName.toLowerCase() === 'body') {
                    return false;
                } else {
                    return elementInside(candidate.parentNode, element);
                }
            };

            var disclaimer = document.querySelector('.c-disclaimer[aria-hidden="false"]');
            window.dataLayer.push({event:'OneTrustGroupsUpdated'});
            if (disclaimer) {
                if (!elementInside(document.activeElement, disclaimer)) {
                    disclaimer.querySelector('button').focus();
                }
            } else {
                document.activeElement.blur();
            }
        }
    </script>

    
    <script>
    (function(w, d) {
        w.config = w.config || {};
        w.config.mustardcut = false;

        
        if (w.matchMedia && w.matchMedia('only screen and (-webkit-min-device-pixel-ratio:0) and (min-color-index:0), (-ms-high-contrast: none), only all and (min--moz-device-pixel-ratio:0) and (min-resolution: 3e1dpcm)').matches) {
            w.config.mustardcut = true;
            d.classList.add('js');
            d.classList.remove('grade-c');
        }
    })(window, document.documentElement);
</script>

    
<script>
    (function () {
        if ( typeof window.CustomEvent === "function" ) return false;
        function CustomEvent ( event, params ) {
            params = params || { bubbles: false, cancelable: false, detail: null };
            var evt = document.createEvent( 'CustomEvent' );
            evt.initCustomEvent( event, params.bubbles, params.cancelable, params.detail );
            return evt;
        }

        CustomEvent.prototype = window.Event.prototype;

        window.CustomEvent = CustomEvent;
    })();
</script>

    
        
    
        
            <!-- Google Tag Manager -->
            <script data-test="gtm-head">
                if (window.config.mustardcut) {
                    (function (w, d, s, l, i) {
                        w[l] = w[l] || [];
                        w[l].push({'gtm.start': new Date().getTime(), event: 'gtm.js'});
                        var f = d.getElementsByTagName(s)[0],
                                j = d.createElement(s),
                                dl = l != 'dataLayer' ? '&l=' + l : '';
                        j.async = true;
                        j.src = 'https://www.googletagmanager.com/gtm.js?id=' + i + dl;
                        
                        j.addEventListener('load', function() {
                            var _ge = new CustomEvent('gtm_loaded', { bubbles: true });
                            d.dispatchEvent(_ge);
                        });
                        f.parentNode.insertBefore(j, f);
                    })(window, document, 'script', 'dataLayer', 'GTM-WCF9Z9');
                }
            </script>
            <!-- End Google Tag Manager -->
        
    


    
    <script class="js-entry">
    if (window.config.mustardcut) {
        (function(w, d) {
            
            
            
                window.Component = {};
                window.suppressShareButton = false;
            

            var currentScript = d.currentScript || d.head.querySelector('script.js-entry');

            
            function catchNoModuleSupport() {
                var scriptEl = d.createElement('script');
                return (!('noModule' in scriptEl) && 'onbeforeload' in scriptEl)
            }

            var headScripts = [
                {'src': '/oscar-static/js/polyfill-es5-bundle-3ae6e1981b.js', 'async': false},
                {'src': '/oscar-static/js/airbrake-es5-bundle-e0a2dbf35f.js', 'async': false},
            ];

            var bodyScripts = [
                {'src': '/oscar-static/js/app-es5-bundle-068a463255.js', 'async': false, 'module': false},
                {'src': '/oscar-static/js/app-es6-bundle-0ca9bb882c.js', 'async': false, 'module': true}
                
                
                    , {'src': '/oscar-static/js/global-article-es5-bundle-6c6c6e21a1.js', 'async': false, 'module': false},
                    {'src': '/oscar-static/js/global-article-es6-bundle-ff57660707.js', 'async': false, 'module': true}
                
            ];

            function createScript(script) {
                var scriptEl = d.createElement('script');
                scriptEl.src = script.src;
                scriptEl.async = script.async;
                if (script.module === true) {
                    scriptEl.type = "module";
                    if (catchNoModuleSupport()) {
                        scriptEl.src = '';
                    }
                } else if (script.module === false) {
                    scriptEl.setAttribute('nomodule', true)
                }
                if (script.charset) {
                    scriptEl.setAttribute('charset', script.charset);
                }

                return scriptEl;
            }

            for (var i = 0; i < headScripts.length; ++i) {
                var scriptEl = createScript(headScripts[i]);
                currentScript.parentNode.insertBefore(scriptEl, currentScript.nextSibling);
            }

            d.addEventListener('DOMContentLoaded', function() {
                for (var i = 0; i < bodyScripts.length; ++i) {
                    var scriptEl = createScript(bodyScripts[i]);
                    d.body.appendChild(scriptEl);
                }
            });

            // Webfont repeat view
            var config = w.config;
            if (config && config.publisherBrand && sessionStorage.fontsLoaded === 'true') {
                d.documentElement.className += ' webfonts-loaded';
            }
        })(window, document);
    }
</script>

    
    
    <link rel="canonical" href="https://link.springer.com/article/10.1007/s00115-021-01104-1"/>
    

    
    <script type="application/ld+json">{"mainEntity":{"headline":"Neurovaskuläre Manifestationen von COVID‑19","description":"Bereits früh nach Beginn der COVID‑19(„coronavirus disease 2019“)-Pandemie wurden Schlaganfälle als Manifestation oder Komplikation einer SARS-CoV-2(„severe acute respiratory syndrome coronavirus 2“)-Infektion beschrieben. Aktuelle Metaanalysen berichten eine Schlaganfallrate von etwa 1,5 %. Schlaganfälle bei COVID‑19-Patienten treten zwar häufiger bei schweren Verläufen der Infektion und bei älteren Patienten mit kardiovaskulären Risiken auf. Nicht selten sind aber auch junge Patienten ohne Risikofaktoren betroffen. Die Schlaganfallmechanismen sind vorwiegend embolisch, die Thromben verschließen häufig große intrakranielle Gefäße und betreffen in mehr als 20 % mehrere Gefäßterritorien, während mikroangiopathische Infarkte selten sind. Die genaue Emboliequelle bleibt bei über 40 % der Betroffenen kryptogen. Die durch das Zusammentreffen einer SARS-CoV-2-Infektion und eines Schlaganfalls bedingte Mortalität beträgt mehr als 15–30 %. Während es in manchen europäischen Regionen zu erheblichen Einschränkungen der Akutversorgung von Schlaganfällen gekommen ist, sind die Behandlungsraten für die Rekanalisationstherapie in Deutschland während der 1. Pandemiewelle weitgehend stabil geblieben. Es stellten sich aber 20–30 % weniger Patienten mit v. a. leichteren Schlaganfällen und transitorischen ischämischen Attacken in Krankenhäusern vor. Die vorliegende Übersichtsarbeit fasst die aktuellen Erkenntnisse zur Epidemiologie und Pathogenese COVID‑19-assoziierter Schlaganfälle zusammen und beschreibt die bisherigen Auswirkungen der Pandemie auf die Schlaganfallakutversorgung.","datePublished":"2021-03-24","dateModified":"2021-03-24","pageStart":"531","pageEnd":"539","license":"http://creativecommons.org/licenses/by/4.0/deed.de","sameAs":"https://doi.org/10.1007/s00115-021-01104-1","keywords":"Neurology,Psychiatry,Psychosomatic Medicine,Psychotherapy,Psychopharmacology,Neurosurgery","image":"","isPartOf":{"name":"Der Nervenarzt","issn":["1433-0407","0028-2804"],"volumeNumber":"92","@type":["Periodical","PublicationVolume"]},"publisher":{"name":"Springer Medizin","logo":{"url":"https://www.springernature.com/app-sn/public/images/logo-springernature.png","@type":"ImageObject"},"@type":"Organization"},"author":[{"name":"Veltkamp, Roland","affiliation":[{"name":"Alfried Krupp Krankenhaus Essen","address":{"name":"Neurologische Klinik, Alfried Krupp Krankenhaus Essen, Essen, Deutschland","@type":"PostalAddress"},"@type":"Organization"},{"name":"Imperial College London","address":{"name":"Department of Brain Sciences, Imperial College London, London, Großbritannien","@type":"PostalAddress"},"@type":"Organization"},{"name":"Universitätsklinikum Heidelberg","address":{"name":"Neurologische Klinik, Universitätsklinikum Heidelberg, Heidelberg, Deutschland","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Purrucker, Jan C.","affiliation":[{"name":"Universitätsklinikum Heidelberg","address":{"name":"Neurologische Klinik, Universitätsklinikum Heidelberg, Heidelberg, Deutschland","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Weber, Ralph","affiliation":[{"name":"Alfried Krupp Krankenhaus Essen","address":{"name":"Neurologische Klinik, Alfried Krupp Krankenhaus Essen, Essen, Deutschland","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"}],"@type":"ScholarlyArticle"},"@context":"https://schema.org","@type":"WebPage"}</script>

</head>
<body class="shared-article-renderer">
    
    
    
        
            <!-- Google Tag Manager (noscript) -->
            <noscript data-test="gtm-body">
                <iframe src="https://www.googletagmanager.com/ns.html?id=GTM-WCF9Z9"
                height="0" width="0" style="display:none;visibility:hidden"></iframe>
            </noscript>
            <!-- End Google Tag Manager (noscript) -->
        
    


    <div class="u-vh-full">
        <a class="c-skip-link" href="#main-content">Skip to main content</a>
        
        <div class="u-hide u-show-following-ad"></div>
        <aside class="c-ad c-ad--728x90" data-test="springer-doubleclick-ad">
            <div class="c-ad__inner">
                <p class="c-ad__label">Advertisement</p>
                    <div id="div-gpt-ad-LB1" data-pa11y-ignore data-gpt data-gpt-unitpath="/270604982/springerlink/115/article" data-gpt-sizes="728x90" style="min-width:728px;min-height:90px" data-gpt-targeting="pos=LB1;articleid=s00115-021-01104-1;"></div>
            </div>
        </aside>

<div class="u-position-relative">
    <header class="c-header u-mb-24" data-test="publisher-header">
        <div class="c-header__container">
            <div class="c-header__brand">
                
    <a id="logo" class="u-display-block" href="/" title="Go to homepage" data-test="springerlink-logo">
        <picture>
            <source type="image/svg+xml" srcset=/oscar-static/images/springerlink/svg/springerlink-253e23a83d.svg>
            <img src=/oscar-static/images/springerlink/png/springerlink-1db8a5b8b1.png alt="SpringerLink" width="148" height="30" data-test="header-academic">
        </picture>
        
        
    </a>


            </div>
            <div class="c-header__navigation">
                
    
        <button type="button"
                class="c-header__link u-button-reset u-mr-24"
                data-expander
                data-expander-target="#popup-search"
                data-expander-autofocus="firstTabbable"
                data-test="header-search-button">
            <span class="u-display-flex u-align-items-center">
                Search
                <svg class="u-icon u-flex-static u-ml-8" width="22" height="22" aria-hidden="true" focusable="false">
                    <use xlink:href="#global-icon-search"></use>
                </svg>
            </span>
        </button>
        <nav>
            <ul class="c-header__menu">
                
                <li class="c-header__item">
                    <a
                        data-test="login-link"
                        class="c-header__link"
                        href="//link.springer.com/signup-login?previousUrl=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs00115-021-01104-1"
                        data-track="click"
                        data-track-category="header"
                        data-track-action="login header"
                        data-track-label="link">Log in</a>
                </li>
                

                
            </ul>
        </nav>
    

    



            </div>
        </div>
    </header>

    
        <div id="popup-search" class="c-popup-search u-mb-16 js-header-search u-js-hide">
            <div class="c-popup-search__content">
                <div class="u-container">
                    <div class="c-popup-search__container" data-test="springerlink-popup-search">
                        <div class="app-search">
    <form role="search" method="GET" action="/search" >
        <label for="search" class="app-search__label">Search SpringerLink</label>
        <div class="app-search__content">
            <input id="search" class="app-search__input" data-search-input autocomplete="off" role="textbox" name="query" type="text" value="">
            <button class="app-search__button" type="submit">
                <span class="u-visually-hidden">Search</span>
                <svg class="u-icon" width="14" height="14" aria-hidden="true" focusable="false">
                    <use xlink:href="#global-icon-search"></use>
                </svg>
            </button>
            
                <input type="hidden" name="searchType" value="publisherSearch">
            
            
        </div>
    </form>
</div>

                    </div>
                </div>
            </div>
        </div>
    
</div>

        

    <div class="u-container u-mt-32 u-mb-32 u-clearfix" id="main-content" data-component="article-container">
        <main class="c-article-main-column u-float-left js-main-column" data-track-component="article body">
            
                
                <div class="c-context-bar u-hide" data-component="context-bar" aria-hidden="true">
                    <div class="c-context-bar__container u-container">
                        <div class="c-context-bar__title">
                            Neurovaskuläre Manifestationen von COVID‑19
                        </div>
                        
    <div class="c-pdf-download u-clear-both">
        <a href="https://link.springer.com/content/pdf/10.1007/s00115-021-01104-1.pdf" class="c-pdf-download__link" data-article-pdf="true" data-readcube-pdf-url="true" data-test="pdf-link" data-draft-ignore="true" data-track="click" data-track-action="download pdf" data-track-label="button" data-track-external>
            
                <span>Download PDF</span>
                <svg aria-hidden="true" focusable="false" width="16" height="16" class="u-icon"><use xlink:href="#global-icon-download"/></svg>
            
        </a>
    </div>


                    </div>
                </div>
            

            <div class="c-pdf-button__container">
                
    <div class="c-pdf-download u-clear-both">
        <a href="https://link.springer.com/content/pdf/10.1007/s00115-021-01104-1.pdf" class="c-pdf-download__link" data-article-pdf="true" data-readcube-pdf-url="true" data-test="pdf-link" data-draft-ignore="true" data-track="click" data-track-action="download pdf" data-track-label="button" data-track-external>
            
                <span>Download PDF</span>
                <svg aria-hidden="true" focusable="false" width="16" height="16" class="u-icon"><use xlink:href="#global-icon-download"/></svg>
            
        </a>
    </div>

            </div>

            <div class="c-article-collection__container">
                
    

            </div>


            <article lang="de">
                <div class="c-article-header">
                    <header>
                        <ul class="c-article-identifiers" data-test="article-identifier">
                            
    
        <li class="c-article-identifiers__item" data-test="article-category">Leitthema</li>
    
    
        <li class="c-article-identifiers__item">
            <span class="c-article-identifiers__open" data-test="open-access">Open Access</span>
        </li>
    
    

                            <li class="c-article-identifiers__item"><a href="#article-info" data-track="click" data-track-action="publication date" data-track-label="link">Published: <time datetime="2021-03-24">24 March 2021</time></a></li>
                        </ul>

                        
                        <h1 class="c-article-title" data-test="article-title" data-article-title="">Neurovaskuläre Manifestationen von COVID‑19</h1><p lang="en">Neurovascular manifestations of COVID‑19</p>
                        <ul class="c-article-author-list js-etal-collapsed" data-etal="25" data-etal-small="3" data-test="authors-list" data-component-authors-activator="authors-list"><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Roland-Veltkamp" data-author-popup="auth-Roland-Veltkamp" data-corresp-id="c1"> Roland Veltkamp<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-email"></use></svg></a><sup class="u-js-hide"><a href="#Aff1">1</a>,<a href="#Aff2">2</a>,<a href="#Aff3">3</a></sup>, </li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Jan_C_-Purrucker" data-author-popup="auth-Jan_C_-Purrucker">Jan C. Purrucker</a><sup class="u-js-hide"><a href="#Aff3">3</a></sup> &amp; </li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Ralph-Weber" data-author-popup="auth-Ralph-Weber">Ralph Weber</a><sup class="u-js-hide"><a href="#Aff1">1</a></sup> </li></ul>
                        <p class="c-article-info-details" data-container-section="info">
                            
    <a data-test="journal-link" href="/journal/115"><i data-test="journal-title">Der Nervenarzt</i></a>

                            <b data-test="journal-volume"><span class="u-visually-hidden">volume</span> 92</b>, <span class="u-visually-hidden">pages </span>531–539 (<span data-test="article-publication-year">2021</span>)<a href="#citeas" class="c-article-info-details__cite-as u-hide-print" data-track="click" data-track-action="cite this article" data-track-label="link">Cite this article</a>
                        </p>
                        
    

                        <div data-test="article-metrics">
                            <div id="altmetric-container">
    <div class="c-article-metrics-bar__wrapper u-clear-both">
        <ul class="c-article-metrics-bar u-list-reset">
            
                <li class=" c-article-metrics-bar__item">
                    <p class="c-article-metrics-bar__count">1490 <span class="c-article-metrics-bar__label">Accesses</span></p>
                </li>
            
            
            
                
                    <li class="c-article-metrics-bar__item">
                        <p class="c-article-metrics-bar__count">1 <span class="c-article-metrics-bar__label">Altmetric</span></p>
                    </li>
                
            
            <li class="c-article-metrics-bar__item">
                <p class="c-article-metrics-bar__details"><a href="/article/10.1007%2Fs00115-021-01104-1/metrics" data-track="click" data-track-action="view metrics" data-track-label="link" rel="nofollow">Metrics <span class="u-visually-hidden">details</span></a></p>
            </li>
        </ul>
    </div>
</div>

                        </div>
                        
    

    

                        
                    </header>
                </div>

                <div data-article-body="true" data-track-component="article body" class="c-article-body">
                    <section aria-labelledby="Abs1" data-title="Zusammenfassung" lang="de"><div class="c-article-section" id="Abs1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Abs1">Zusammenfassung</h2><div class="c-article-section__content" id="Abs1-content"><p>Bereits früh nach Beginn der COVID‑19(„coronavirus disease 2019“)-Pandemie wurden Schlaganfälle als Manifestation oder Komplikation einer SARS-CoV-2(„severe acute respiratory syndrome coronavirus 2“)-Infektion beschrieben. Aktuelle Metaanalysen berichten eine Schlaganfallrate von etwa 1,5 %. Schlaganfälle bei COVID‑19-Patienten treten zwar häufiger bei schweren Verläufen der Infektion und bei älteren Patienten mit kardiovaskulären Risiken auf. Nicht selten sind aber auch junge Patienten ohne Risikofaktoren betroffen. Die Schlaganfallmechanismen sind vorwiegend embolisch, die Thromben verschließen häufig große intrakranielle Gefäße und betreffen in mehr als 20 % mehrere Gefäßterritorien, während mikroangiopathische Infarkte selten sind. Die genaue Emboliequelle bleibt bei über 40 % der Betroffenen kryptogen. Die durch das Zusammentreffen einer SARS-CoV-2-Infektion und eines Schlaganfalls bedingte Mortalität beträgt mehr als 15–30 %. Während es in manchen europäischen Regionen zu erheblichen Einschränkungen der Akutversorgung von Schlaganfällen gekommen ist, sind die Behandlungsraten für die Rekanalisationstherapie in Deutschland während der 1. Pandemiewelle weitgehend stabil geblieben. Es stellten sich aber 20–30 % weniger Patienten mit v. a. leichteren Schlaganfällen und transitorischen ischämischen Attacken in Krankenhäusern vor. Die vorliegende Übersichtsarbeit fasst die aktuellen Erkenntnisse zur Epidemiologie und Pathogenese COVID‑19-assoziierter Schlaganfälle zusammen und beschreibt die bisherigen Auswirkungen der Pandemie auf die Schlaganfallakutversorgung.</p></div></div></section><section aria-labelledby="Abs2" data-title="Abstract" lang="en"><div class="c-article-section" id="Abs2-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Abs2">Abstract</h2><div class="c-article-section__content" id="Abs2-content"><p>Even early at the beginning of the coronavirus disease 2019 (COVID‑19) pandemic, stroke was described as a manifestation or complication of infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Current meta-analyses reported a stroke rate of approximately 1.5%. Stroke in COVID‑19 positive patients occurs more frequently in severe courses of the infection and in older patients with cardiovascular comorbidities; however, young patients without cardiovascular risk factors are also not uncommonly affected. The mechanisms of stroke are predominantly embolic. The thrombi frequently occlude large intracranial vessels and in more than 20% affect multiple vascular territories, whereas infarctions due to small vessel disease are uncommon. The exact source of the embolism remains cryptogenic in more than 40% of patients. The mortality caused by the co-occurrence of a SARS-CoV‑2 infection and a stroke exceeds 15–30%. While acute stroke treatment was severely affected in some European regions, the rates of recanalization treatment in Germany largely remained stable during the first pandemic wave; however, 20–30% fewer patients with minor stroke and transient ischemic attacks (TIA) presented to hospitals during the first wave in spring 2020. The present narrative review summarizes the current evidence regarding the epidemiology and pathogenesis of stroke associated with COVID‑19 and describes the effect of the pandemic so far on the provision of acute stroke treatment.</p></div></div></section>
                    
    


                    

                    

                    
                        
                            <section data-title="Hintergrund"><div class="c-article-section" id="Sec1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec1">Hintergrund</h2><div class="c-article-section__content" id="Sec1-content"><p>Bereits wenige Monate nach dem Ausbruch der durch das „severe acute respiratory syndrome corona virus type 2“ (SARS-CoV-2) bedingten COVID‑19(„coronavirus disease 2019“)-Pandemie wurde in einer ersten chinesischen Fallserie eine erhöhte Schlaganfallrate bei COVID‑19-positiven Patienten beschrieben [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 17" title="Li Y, Li M, Wang M et al (2020) Acute cerebrovascular disease following COVID‑19: a single center, retrospective, observational study. Stroke Vasc Neurol 5:279–284" href="/article/10.1007/s00115-021-01104-1#ref-CR17" id="ref-link-section-d39729855e430">17</a>]. Von 219 COVID‑19-positiven Patienten hatten 11 Patienten (5 %) einen Schlaganfall erlitten, davon 10 einen ischämischen. Große Aufmerksamkeit erlangte bald darauf ein Bericht über 5 junge COVID‑19-Patienten aus New York, die schwere ischämische Schlaganfälle ohne erkennbare Risikokonstellation hatten [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 23" title="Oxley TJ, Mocco J, Majidi S et al (2020) Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med 382:e60" href="/article/10.1007/s00115-021-01104-1#ref-CR23" id="ref-link-section-d39729855e433">23</a>]. Auch aus anderen Ländern wurde über eine Häufung arterieller und vor allem venöser thrombembolischer Komplikationen in Zusammenhang mit SARS-CoV‑2 berichtet. Diese Berichte legten nahe, dass eine Infektion mit SARS-CoV‑2 ähnlich oder sogar häufiger als andere Virusinfektionen Schlaganfälle verursachen oder zumindest auslösen kann. Die Mechanismen der Schlaganfallauslösung in Zusammenhang mit COVID‑19 sind bislang aber nur teilweise verstanden.</p><p>In einigen europäischen und amerikanischen Regionen und Metropolen hat die Überlastung der medizinischen Versorgungssysteme durch die COVID‑19-Pandemie zeitweise die etablierten Versorgungswege des Schlaganfalls erheblich beeinträchtigt. Diese Einschränkungen betreffen alle Glieder der Schlaganfallversorgungskette einschließlich der Rettungsdienste, der Notfallambulanzen, der neuroradiologischen Interventionen und der Stroke-Units. Neben der Belastung des Gesundheitssystems haben insbesondere auch Ängste von Patienten vor einer SARS-CoV-2-Infektion im Krankenhaus zu einer verminderten Präsentation von Patienten mit leichten Schlaganfällen und transitorischen ischämischen Attacken (TIAs) geführt.</p><p>Die vorliegende Übersichtsarbeit fasst zunächst die bisherigen epidemiologischen Daten zur Häufigkeit von Schlaganfällen und verschiedenen Schlaganfallsubtypen bei COVID‑19 zusammen. Im zweiten Teil werden aktuelle Konzepte zur Schlaganfallpathogenese bei COVID‑19 vorgestellt und ein Vergleich zur Influenza gezogen. Anschließend werden die bisherigen Auswirkungen der COVID‑19-Pandemie auf die akute Schlaganfallversorgung beschrieben. Die sich hieraus ergebenden Konsequenzen werden abschließend erörtert.</p></div></div></section><section data-title="Schlaganfallraten bei COVID‑19-infizierten Patienten"><div class="c-article-section" id="Sec2-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec2">Schlaganfallraten bei COVID‑19-infizierten Patienten</h2><div class="c-article-section__content" id="Sec2-content"><p>Seit den erwähnten ersten Fallserien sind mehrere systematische Reviews und Metaanalysen zur Häufigkeit eines Schlaganfalls bei COVID‑19-Patienten, zu den Risikofaktoren und zur Prognose erschienen.</p><p>Nannoni und Kollegen berücksichtigen in ihrem systematischen Review alle bis September 2020 publizierten Studien, die mindestens 5 COVID‑19-positive Schlaganfallpatienten umfassten. In der Metaanalyse mit insgesamt 108.571 COVID‑19-positiven Patienten aus Asien, Europa und Nordamerika lag die gepoolte Inzidenz eines zerebrovaskulären Ereignisses bei 1,4 % (95 %-Konfidenzintervall[KI] 0,4–8,1 %; [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 22" title="Nannoni S, De Groot R, Bell S et al (2021) Stroke in COVID‑19: a systematic review and meta-analysis. Int J Stroke 16:137–149" href="/article/10.1007/s00115-021-01104-1#ref-CR22" id="ref-link-section-d39729855e450">22</a>]). 87,4 % der COVID‑19-positiven Patienten erlitten einen ischämischen Schlaganfall und 11,6 % eine intrazerebrale Blutung. COVID‑19-positive Schlaganfallpatienten waren im Vergleich zu nichtinfizierten Schlaganfallpatienten im Median 6 Jahre jünger und bei Aufnahme schwerer betroffen mit einem im Median um 5 Punkte höheren Punktwert auf der Schlaganfallskala der National Institutes of Health. COVID‑19-Patienten hatten zudem eine signifikant höhere Rate an großen Gefäßverschlüssen (Odds Ratio 2,73) und eine signifikant höhere Mortalität (33,3 vs. 11,6 %; OR 5,21). Bei 52,5 % der Betroffenen lagen die Infarkte in mehreren vaskulären Territorien. Die Schlaganfallursache konnte häufig (44,5 %) bei COVID‑19-positiven Schlaganfallpatienten nicht sicher geklärt werden. 19,1 % der ca. 1200 analysierbaren COVID‑19-positiven ischämischen Schlaganfallpatienten erhielten eine systemische Thrombolyse. Die gepoolte Thrombektomierate der COVID‑19-positiven Schlaganfallpatienten war mit 25,9 % sehr hoch, was zu der signifikant höheren Rate an berichteten großen Gefäßverschlüssen passt.</p><blockquote class="c-blockquote c-blockquote--right"><div class="c-blockquote__body"><p>“Ein möglicher Selektions- und/oder Publikationsbias muss berücksichtigt werden”
                            </p></div></blockquote><p>In einer im November 2020 publizierten multizentrischen Fall-Kontroll-Studie aus England, die insgesamt 1470 ischämische und hämorrhagische Schlaganfallpatienten umfasste, zeigten sich im Gegensatz zu den Ergebnissen der o. g. Metaanalyse keine signifikanten Unterschiede bezüglich des Alters COVID-positiver und -negativer Schlaganfallpatienten [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 24" title="Perry RJ, Smith CJ, Roffe C et al (2020) Characteristics and outcomes of COVID‑19 associated stroke: a UK multicentre case-control study. J Neurol Neurosurg Psychiatry 92:242–248" href="/article/10.1007/s00115-021-01104-1#ref-CR24" id="ref-link-section-d39729855e459">24</a>], sodass natürlich bei allen gefunden Assoziationen immer auch ein möglicher Selektions- und/oder Publikationsbias berücksichtigt werden muss. Dafür sprechen auch die Ergebnisse einer weiteren systematischen Übersichtsarbeit, die die Schlaganfallinzidenzen aus Studien bis Mai 2020 bei COVID-positiven Patienten untersuchte [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 7" title="Cheng R, Leedy D (2020) COVID‑19 and acute myocardial injury: the heart of the matter or an innocent bystander? Heart 106:1122–1124" href="/article/10.1007/s00115-021-01104-1#ref-CR7" id="ref-link-section-d39729855e462">7</a>]. Diese lag mit 1,8 % (95 %-KI 0,9–3,7 %) etwas höher als bei Nannoni et al., es zeigte sich aber auch hier eine sehr hohe Heterogenität der eingeschlossenen Studien. Einschränkend muss aber bei dieser Metaanalyse erwähnt werden, dass sie nur 3306 COVID-positive Patienten umfasste. Auch in dieser Metaanalyse war die Mortalität mit 34,4 % (95 %KI 27,2–42,4 %) bei den COVID‑19-positiven Schlaganfallpatienten sehr hoch. In einer multizentrischen retrospektiven Analyse von 8163 COVID‑19-Patienten in den USA entwickelten 1,3 % einen ischämischen Schlaganfall verglichen mit 1,0 % ohne COVID‑19. Die Mortalität im Krankenhaus bei Patienten mit ischämischem Schlaganfall war mit 19,4 % (COVID‑19) niedriger als in vorgenannter Metaanalyse und unterschied sich nicht von Nicht-COVID‑19-Patienten (21,6 %; <i>p</i> = 0,66; [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 26" title="Qureshi AI, Baskett WI, Huang W et al (2021) Acute Ischemic stroke and COVID‑19: an analysis of 27 676 patients. Stroke. &#xA;                  https://doi.org/10.1161/STROKEAHA.120.031786&#xA;                  &#xA;                " href="/article/10.1007/s00115-021-01104-1#ref-CR26" id="ref-link-section-d39729855e468">26</a>]).</p><p>Aufgrund eines sehr wahrscheinlichen Publikations- und Berichtsbias soll hier kurz die Arbeit von Bekelis und Mitarbeitern aus dem stark betroffenen Staat New York erwähnt werden, die in ihrer Analyse von Entlassungsdaten von 24.808 Patienten (davon waren 2513 COVID-positiv) in den Monaten Januar bis April 2020 keine positive Assoziation zwischen einer SARS-CoV-2-Infektion und ischämischem Schlaganfall fanden (OR 0,25; 95 %-KI 0,16–0,40; [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 3" title="Bekelis K, Missios S, Ahmad J et al (2020) Ischemic stroke occurs less frequently in patients with COVID‑19: a multicenter cross-sectional study. Stroke 51:3570–3576" href="/article/10.1007/s00115-021-01104-1#ref-CR3" id="ref-link-section-d39729855e475">3</a>]).</p><p>Landesweite Daten aus der 1. Pandemiewelle wurden bisher aus Dänemark und Deutschland publiziert. In dem landesweiten dänischen Register, das alle Krankenhausaufnahmen systematisch erfasst, wurde mithilfe des sog. „Self-controlled-case-series“-Studiendesign die Inzidenz des Auftretens eines ischämischen Schlaganfalls und akuten Herzinfarktes anhand der ICD-10(International Statistical Classification of Diseases and Related Health Problems 10)-Kodierungen bestimmt [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 21" title="Modin D, Claggett B, Sindet-Pedersen C et al (2020) Acute COVID‑19 and the incidence of Ischemic stroke and acute myocardial infarction. Circulation 142:2080–2082" href="/article/10.1007/s00115-021-01104-1#ref-CR21" id="ref-link-section-d39729855e481">21</a>]. Insgesamt hatten sich in dem Beobachtungszeitraum der Studie 5119 Patienten mit COVID‑19 infiziert. Von diesen erlitten 44 einen ischämischen Schlaganfall und 18 einen akuten Herzinfarkt. Das ischämische Schlaganfallrisiko in den ersten 14 Tagen nach laborchemischer Diagnosestellung einer COVID‑19-Infektion war 10-fach höher verglichen zu dem vor der Infektion gelegenen Zeitraum von bis zu 180 Tagen. Dieser Unterschied blieb auch statistisch signifikant, wenn der Beobachtungszeitraum nach der Diagnosestellung auf 31 Tage verlängert wurde. Das Risiko, einen akuten Herzinfarkt in den ersten 14 Tagen nach der Diagnosestellung zu erleiden, war ungefähr 5‑fach erhöht.</p><p>In Deutschland hatten von 68.913 Patienten, die im Zeitraum von 16.01.2020 bis 15.05.2020 mit der Hauptdiagnose eines ischämischen Schlaganfalls im Krankenhaus aufgenommen wurden, 213 Patienten eine zusätzliche COVID‑19-Infektion als Nebendiagnose [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 27" title="Richter D, Bartig D, Krogias C et al (2020) Letter to the editor: risk comorbidities of COVID‑19 in Parkinson′s disease patients in Germany. Neurol Res Pract 2:22" href="/article/10.1007/s00115-021-01104-1#ref-CR27" id="ref-link-section-d39729855e487">27</a>]. Das Alter der Patienten lag mit 76 ± 20 Jahren nichtsignifikant höher als bei Schlaganfallpatienten ohne COVID‑19-Infektion (74 ± 19 Jahre). Bezüglich der Geschlechterverteilung gab es keine signifikanten Unterschiede zwischen infizierten und nichtinfizierten Schlaganfallpatienten. Ebenso unterschied sich die Häufigkeit der verabreichten intravenösen Thrombolyse bei COVID‑19-positiven Schlaganfallpatienten nicht von der Rate bei nichtinfizierten Schlaganfallpatienten (16,4 vs. 16,2 %), während die mechanische Thrombektomie signifikant seltener bei COVID‑19-Patienten durchgeführt wurde (3,8 vs. 7,7 %). Die Krankenhaussterblichkeit war in Deutschland bei den COVID‑19-positiven Schlaganfallpatienten erheblich erhöht (22,5 vs. 7,7 %). Bei 172 Patienten, die ursprünglich aufgrund einer COVID‑19-Infektion stationär aufgenommen worden waren, wurde die Nebendiagnose eines ischämischen Schlaganfalls kodiert. Die Krankenhaussterblichkeit bei diesen Patienten lag bei 49,4 %. Unter Berücksichtigung beider Konstellationen betrug die Krankenhaussterblichkeit bei COVID‑19-infizierten Patienten mit einem ischämischen Schlaganfall als Haupt- oder Nebendiagnose in Deutschland insgesamt 34,6 %.</p><blockquote class="c-blockquote c-blockquote--right"><div class="c-blockquote__body"><p>“Die Mortalität war in der BRD bei COVID‑19-positiven Schlaganfallpatienten erheblich erhöht”
                            </p></div></blockquote><p>Zusammenfassend geht eine SARS-CoV-2-Infektion nach den bisher vorliegenden Daten mit einem leicht erhöhten Schlaganfallrisiko einher. Es treten überwiegend embolische Schlaganfälle in größeren Hirngefäßen auf, die mit einer deutlich erhöhten Mortalität einhergehen. In Tab. <a data-track="click" data-track-label="link" data-track-action="table anchor" href="/article/10.1007/s00115-021-01104-1#Tab1">1</a> sind die wichtigsten epidemiologischen Daten zusammengefasst.</p><div class="c-article-table" data-test="inline-table" data-container-section="table" id="table-1"><figure><figcaption class="c-article-table__figcaption"><b id="Tab1" data-test="table-caption">Tab. 1 Zusammenfassung wichtiger epidemiologischer Kennzahlen für COVID‑19-Patienten mit akuten Schlaganfällen</b></figcaption><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="table-link" data-track="click" data-track-action="view table" data-track-label="button" rel="nofollow" href="/article/10.1007/s00115-021-01104-1/tables/1" aria-label="Full size table 1"><span>Full size table</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div></div></div></section><section data-title="Mechanismen der Schlaganfallpathogenese bei COVID‑19"><div class="c-article-section" id="Sec3-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec3">Mechanismen der Schlaganfallpathogenese bei COVID‑19</h2><div class="c-article-section__content" id="Sec3-content"><p>Hinweise auf die Pathogenese von Schlaganfällen bei mit SARS-CoV‑2 infizierten Patienten ergeben sich aus epidemiologischen Daten, aus bildgebenden und laborchemischen Befunden und aus dem wachsenden Verständnis der molekularen Pathomechanismen von COVID‑19.</p><p>Die Genese von Schlaganfällen ist heterogen und multifaktoriell und hängt von der individuellen Konstellation bei COVID‑19-Patienten ab. Einerseits kann die SARS-CoV-2-Infektion bei Patienten mit vorbestehender kardiovaskulärer Erkrankung ein akutes Schlaganfallereignis auslösen oder begünstigen [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 31" title="South K, Mcculloch L, Mccoll BW et al (2020) Preceding infection and risk of stroke: an old concept revived by the COVID‑19 pandemic. Int J Stroke 15:722–732" href="/article/10.1007/s00115-021-01104-1#ref-CR31" id="ref-link-section-d39729855e1003">31</a>]. Andererseits gibt es Belege dafür, dass die SARS-CoV-2-Infektion über inflammatorische, vaskuläre oder thrombotische Prozesse zu zerebralen Thrombembolien bei zuvor kardiovaskulär gesunden Menschen führen kann.</p><blockquote class="c-blockquote c-blockquote--right"><div class="c-blockquote__body"><p>“Das Zusammenspiel inflammatorischer Prozesse begünstigt die Gerinnselbildung”
                            </p></div></blockquote><p>Das SARS-CoV-2-Virus kann direkt oder über inflammatorische Prozesse eine prothrombotische Diathese hervorrufen [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 10" title="Hess DC, Eldahshan W, Rutkowski E (2020) COVID‑19-related stroke. Transl Stroke Res 11:322–325" href="/article/10.1007/s00115-021-01104-1#ref-CR10" id="ref-link-section-d39729855e1012">10</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 12" title="Iba T, Levy JH, Warkentin TE et al (2019) Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation. J Thromb Haemost 17:1989–1994" href="/article/10.1007/s00115-021-01104-1#ref-CR12" id="ref-link-section-d39729855e1015">12</a>]. Die Aktivierung der Gerinnungskaskade bei Patienten mit schwerer COVID‑19-Erkrankung ist durch den Anstieg von D‑Dimer und Fibrinogen im Plasma belegt. Durch die Aktivierung des Immunsystems kann es zur Freisetzung proinflammatorischer Zytokine [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 11" title="Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497–506" href="/article/10.1007/s00115-021-01104-1#ref-CR11" id="ref-link-section-d39729855e1018">11</a>], einer daraus resultierenden Plaqueruptur und einer Thrombusauflagerung bei Patienten mit einer Arteriosklerose kommen [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 18" title="Marchandot B, Sattler L, Jesel L et al (2020) COVID‑19 related Coagulopathy: a distinct entity? J Clin Med 31:1651" href="/article/10.1007/s00115-021-01104-1#ref-CR18" id="ref-link-section-d39729855e1021">18</a>]. Auch Antiphospholipidantikörper und eine damit verbundene Hyperkoagulabilität sind bei COVID‑19-positiven Patienten mit multiplen embolischen Infarkten berichtet worden [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 38" title="Zhang Y, Xiao M, Zhang S et al (2020) Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med 382:e38" href="/article/10.1007/s00115-021-01104-1#ref-CR38" id="ref-link-section-d39729855e1024">38</a>].</p><p>Das SARS-CoV-2-Virus nutzt den Angiotensin-converting-enzyme-2(ACE2)-Rezeptor, um in die Wirtszellen einzudringen [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 39" title="Zhou P, Yang XL, Wang XG et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579:270–273" href="/article/10.1007/s00115-021-01104-1#ref-CR39" id="ref-link-section-d39729855e1031">39</a>]. Der ACE2-Rezeptor wird neben der Lunge auch im Herzen und in Endothelzellen exprimiert. Das Virus kann in Endothelzellen zu einer Dysfunktion und einer prothrombotischen Veränderung der Gefäßinnenschicht führen [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 36" title="Varga Z, Flammer AJ, Steiger P et al (2020) Endothelial cell infection and endotheliitis in COVID‑19. Lancet 395:1417–1418" href="/article/10.1007/s00115-021-01104-1#ref-CR36" id="ref-link-section-d39729855e1034">36</a>]. Das Herz, eine häufige Quelle embolischer Schlaganfälle auch unter normalen Umständen, gilt ebenfalls als wichtiger Angriffspunkt für das SARS-CoV-2-Virus [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 7" title="Cheng R, Leedy D (2020) COVID‑19 and acute myocardial injury: the heart of the matter or an innocent bystander? Heart 106:1122–1124" href="/article/10.1007/s00115-021-01104-1#ref-CR7" id="ref-link-section-d39729855e1037">7</a>]. Zu den verschiedenen kardialen Manifestationen von COVID‑19 zählen eine Myokarditis, eine inflammatorische oder Stressmyokardiopathie, eine koronare Ischämie und Herzrhythmusstörungen. Ähnlich wie bei den oben genannten Gefäßerkrankungen kann das Zusammenspiel inflammatorischer Prozessen die Gerinnselbildung auch im Herzen begünstigen. Schließlich ist die häufig schwere Hypoxämie bei COVID-assoziierter Pneumonie besonders bedrohlich für Patienten mit hochgradigen, hämodynamisch relevanten extra- und intrakraniellen Stenosen, da ihre vasomotorische Reservekapazität zur Kompensation einer systemischen Hypoxie bereits erschöpft ist.</p><p>Ein erhöhtes Schlaganfallrisiko infolge einer viralen Infektion ist kein für COVID‑19 spezifisches Phänomen [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 31" title="South K, Mcculloch L, Mccoll BW et al (2020) Preceding infection and risk of stroke: an old concept revived by the COVID‑19 pandemic. Int J Stroke 15:722–732" href="/article/10.1007/s00115-021-01104-1#ref-CR31" id="ref-link-section-d39729855e1043">31</a>]. Aufschlussreich ist insbesondere der Vergleich mit der Influenza, einer anderen epidemisch auftretenden viralen Atemwegserkrankung. Eine retrospektive Analyse administrativer Daten von akuten Schlaganfällen zwischen 1994 und 2001, einschließlich Subarachnoidalblutungen und TIAs, berichtete einen schwachen Zusammenhang zwischen Influenzaraten und der Schlaganfallinzidenz [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 8" title="Field TS, Zhu H, Tarrant M et al (2004) Relationship between supra-annual trends in influenza rates and stroke occurrence. Neuroepidemiology 23:228–235" href="/article/10.1007/s00115-021-01104-1#ref-CR8" id="ref-link-section-d39729855e1046">8</a>]. Eine Verdreifachung der Influenzarate führte zu einem 6%igen Anstieg der Schlaganfallinzidenz. Eine weitere Studie berichtete ein erhöhtes individuelles Schlaganfallrisiko nach bestätigter Influenzainfektion verglichen mit anderen Infektionen [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 37" title="Warren-Gash C, Blackburn R, Whitaker H et al (2018) Laboratory-confirmed respiratory infections as triggers for acute myocardial infarction and stroke: a self-controlled case series analysis of national linked datasets from Scotland. Eur Respir J. &#xA;                  https://doi.org/10.1183/13993003.01794-2017&#xA;                  &#xA;                " href="/article/10.1007/s00115-021-01104-1#ref-CR37" id="ref-link-section-d39729855e1049">37</a>]. Allerdings war das Zeitfenster nach der Infektion mit 1 bis 3 Tagen nach dem Influenzanachweis sehr kurz und die Konfidenzintervalle waren sehr groß. Eine Analyse von Registerdaten aus Südlondon, die die Inzidenz in Bezug auf nichtindividualisierte nationale Influenzaüberwachungsdaten auswertete, fand ebenfalls ein kurzes Intervall. Die stärkste Assoziation zwischen Schlaganfall und Influenzainzidenz lag innerhalb einer Woche nach Influenzainfektionen, während nach einem 5‑Wochen-Zeitraum keine Schlaganfallhäufung mehr nachweisbar war [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 33" title="Toschke AM, Heuschmann PU, Wood O et al (2009) Temporal relationship between influenza infections and subsequent first-ever stroke incidence. Age Ageing 38:100–103" href="/article/10.1007/s00115-021-01104-1#ref-CR33" id="ref-link-section-d39729855e1052">33</a>]. Durch Analyse von Routinedaten aus dem Gesundheitswesen konnte die größte Wahrscheinlichkeit für einen späteren Schlaganfall innerhalb von 15 Tagen nach einer Influenzainfektion ermittelt werden, während nach 60 Tagen kein erhöhtes Risiko mehr vorzuliegen scheint [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 5" title="Boehme AK, Luna J, Kulick ER et al (2018) Influenza-like illness as a trigger for ischemic stroke. Ann Clin Transl Neurol 5:456–463" href="/article/10.1007/s00115-021-01104-1#ref-CR5" id="ref-link-section-d39729855e1055">5</a>].</p><blockquote class="c-blockquote c-blockquote--right"><div class="c-blockquote__body"><p>“Das Schlaganfallrisiko ist bei COVID‑19-Infektion im Vergleich zu Influenza erhöht”
                            </p></div></blockquote><p>Vergleichende Analysen von COVID‑19 und Influenza sind derzeit noch rar. Eine Arbeit aus New York, die an zwei Klinikstandorten die Schlaganfallrate bei COVID‑19-Patienten aus der 1. Welle (März bis Mai 2020) mit denen früherer Influenzapandemien (2016 bis Mai 2018) verglich, fand eine deutlich höhere Wahrscheinlichkeit eines ischämischen Schlaganfalls bei Patienten mit COVID‑19-Infektion (31/1916; 1,6 %) verglichen mit Influenza (3/1486, 0,2 %). Nach Adjustierung für generelle Schlaganfallrisikofaktoren war das relative Risiko 7,6-mal höher bei COVID‑19 [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 19" title="Merkler AE, Parikh NS, Mir S et al (2020) Risk of Ischemic stroke in patients with Coronavirus disease 2019 (COVID‑19) vs patients with influenza. JAMA Neurol 77:1–7" href="/article/10.1007/s00115-021-01104-1#ref-CR19" id="ref-link-section-d39729855e1064">19</a>]. In nur rund einem Viertel der Schlaganfallfälle bei COVID‑19 war der akute Schlaganfall der ursprüngliche Grund für die Klinikvorstellung gewesen. Vielmehr traten bei 74 % die Schlaganfallsymptome erst während des Klinikaufenthaltes auf. Die Schlaganfallrate unterschied sich nicht zwischen Patienten mit Symptomen einer Atemwegserkrankung bei Klinikvorstellung und asymptomatischen Patienten mit Identifikation der Infektion im Routinescreening (1,5 vs. 1,9 %). Zwischen den ersten Symptomen der COVID‑19-Infektion und der Schlaganfalldiagnose vergingen im Median 16 Tage (Interquartilsbereich, 5–28; [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 19" title="Merkler AE, Parikh NS, Mir S et al (2020) Risk of Ischemic stroke in patients with Coronavirus disease 2019 (COVID‑19) vs patients with influenza. JAMA Neurol 77:1–7" href="/article/10.1007/s00115-021-01104-1#ref-CR19" id="ref-link-section-d39729855e1067">19</a>]). Die längerfristigen Auswirkungen einer COVID‑19-Infektion auf das Schlaganfallrisiko sind noch nicht bekannt.</p><p>Interessant ist, inwiefern die rasch entwickelten Impfstoffe gegen die SARS-CoV-2-Infektion [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 25" title="Polack FP, Thomas SJ, Kitchin N et al (2020) Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 383:2603–2615" href="/article/10.1007/s00115-021-01104-1#ref-CR25" id="ref-link-section-d39729855e1073">25</a>] einen Effekt auf die zukünftige Inzidenz kardiovaskulärer Erkrankungen einschließlich des Schlaganfalls haben werden. Bei der Influenza zeigte eine Metaanalyse von Beobachtungsstudien aus den Jahren 2002 bis 2014 ein verringertes Risiko eines Schlaganfalls bei Patienten, die eine Impfung erhalten hatten [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 16" title="Lee KR, Bae JH, Hwang IC et al (2017) Effect of influenza vaccination on risk of stroke: a systematic review and meta-analysis. Neuroepidemiology 48:103–110" href="/article/10.1007/s00115-021-01104-1#ref-CR16" id="ref-link-section-d39729855e1076">16</a>]. Vergleichbare Daten zu neueren Influenzaserotypen und -impfungen fehlen noch. Eine gepoolte Analyse prospektiver Studien berichtete von keiner Reduktion durch eine Influenzaimpfung eines gemeinsamen Endpunkts aus nichttödlichem Myokardinfarkt, nichttödlichem Schlaganfall oder Tod durch vaskuläre Ursache innerhalb eines 2‑Jahres-Beobachtungszeitraum nach einem kürzlich atherosklerotischen Schlaganfallereignis [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 15" title="Lavallee PC, Labreuche J, Fox KM et al (2014) Influenza vaccination and cardiovascular risk in patients with recent TIA and stroke. Neurology 82:1905–1913" href="/article/10.1007/s00115-021-01104-1#ref-CR15" id="ref-link-section-d39729855e1079">15</a>]. Eine Metaanalyse von 6 randomisierten klinischen Studien berichtete ein niedrigeres relatives Risiko eines schweren kardiovaskulären Ereignisses nach einem Jahr nach Influenzaimpfung von 0,64 [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 35" title="Udell JA, Zawi R, Bhatt DL et al (2013) Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA 310:1711–1720" href="/article/10.1007/s00115-021-01104-1#ref-CR35" id="ref-link-section-d39729855e1082">35</a>].</p></div></div></section><section data-title="Hirnblutungen und Sinusthrombosen"><div class="c-article-section" id="Sec4-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec4">Hirnblutungen und Sinusthrombosen</h2><div class="c-article-section__content" id="Sec4-content"><p>Intrazerebrale und andere intrakranielle Blutungen sind bei COVID‑19-Patienten in Fallberichten und Fallserien berichtet worden. In einer systematischen Übersichtsarbeit waren 40 % der intrazerebralen Hämatome lobär gelegen, 20 % der Patienten hatten bilaterale Blutungen. Allerdings hat nur ein kleiner Anteil der mit einer COVID‑19-Infektion hospitalisierten Patienten eine Hirnblutung [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 22" title="Nannoni S, De Groot R, Bell S et al (2021) Stroke in COVID‑19: a systematic review and meta-analysis. Int J Stroke 16:137–149" href="/article/10.1007/s00115-021-01104-1#ref-CR22" id="ref-link-section-d39729855e1093">22</a>]. Ein Anstieg der Inzidenz von Hirnblutungen durch eine COVID‑19-Infektion wurde bislang nicht gezeigt [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 34" title="Tsivgoulis G, Palaiodimou L, Zand R et al (2020) COVID‑19 and cerebrovascular diseases: a comprehensive overview. Ther Adv Neurol Disord 13:1756286420978004" href="/article/10.1007/s00115-021-01104-1#ref-CR34" id="ref-link-section-d39729855e1096">34</a>]. Potenzielle Faktoren, die eine Hirnblutung bei COVID‑19 begünstigen könnten, stellen eine COVID‑19-assozierte Koagulopathie, Organversagen und der Einsatz von Antikoagulanzien dar. Die häufig atypische, bilaterale Lokalisation der Blutungen könnte auf eine COVID‑19-assoziierte Vasopathie hindeuten. Auch sind zerebrale Mikroblutungen bei kritisch kranken COVID‑19-Patienten im Corpus callosum und in subkortikalen Arealen berichtet worden.</p><p>Venöse thrombembolische Ereignisse stellen häufige Komplikationen einer COVID‑19-Erkrankung dar. Interessanterweise gibt es auch Fallberichte und Übersichtsarbeiten von COVID‑19-Patienten mit Sinusthrombose oder Thrombose der äußeren und inneren Hirnvenen [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 2" title="Baldini T, Asioli GM, Romoli M et al (2021) Cerebral venous thrombosis and severe acute respiratory syndrome coronavirus‑2 infection: a systematic review and meta-analysis. Eur J Neurol. &#xA;                  https://doi.org/10.1111/ene.14727&#xA;                  &#xA;                " href="/article/10.1007/s00115-021-01104-1#ref-CR2" id="ref-link-section-d39729855e1102">2</a>]. Bei einer Hirnblutung sollte daher differenzialdiagnostisch an eine venöse Stauungsblutung gedacht werden. Bei COVID‑19-Patienten mit Kopfschmerzen, epileptischen Anfällen oder einer Vigilanzminderung sollte auch  eine venöse Thrombose  in Betracht gezogen werden.</p></div></div></section><section data-title="Einfluss der COVID‑19-Pandemie auf die Behandlung des akuten Schlaganfalls"><div class="c-article-section" id="Sec5-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec5">Einfluss der COVID‑19-Pandemie auf die Behandlung des akuten Schlaganfalls</h2><div class="c-article-section__content" id="Sec5-content"><p>Schon in den ersten Wochen nach den Mitte März 2020 in Deutschland eingeführten Shutdown-Maßnahmen wurde von vielen Kollegen der deutschen Stroke-Units über einen deutlichen Rückgang der stationär behandelten Schlaganfallpatienten berichtet. Inzwischen liegen aus allen fünf dauerhaft bewohnten Kontinenten Daten zu dem Phänomen der „verschwundenen Schlaganfallpatienten“ vor. Eine Metaanalyse, die neun regionale Studien aus China, Europa und den USA mit insgesamt 59.233 Patienten umfasste, ergab, dass es während der COVID‑19-Pandemie zu nur 64 % der vor der Pandemie auftretenden Schlaganfallnotfallalarmierungen und Krankenhauseinweisungen kam [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 13" title="July J, Pranata R (2020) Impact of the Coronavirus disease pandemic on the number of strokes and mechanical thrombectomies: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis 29:105185" href="/article/10.1007/s00115-021-01104-1#ref-CR13" id="ref-link-section-d39729855e1113">13</a>]. Die Zahl der Thrombolysetherapien verringerte sich um 31 %, die Zahl der Thrombektomien um 22 % im Vergleich zu der Zeit vor der Pandemie.</p><p>In Dänemark wurden in den ersten 3 Wochen nach dem Lockdown im März 2020 signifikant weniger Patienten mit einer TIA und einem ischämischen Schlaganfall stationär aufgenommen als in den Jahren 2017 bis 2019. Hingegen zeigte sich kein signifikanter Rückgang bei den im Krankenhaus behandelten Patienten mit einem hämorrhagischen Schlaganfall [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Butt JH, Fosbol EL, Ostergaard L et al (2020) Effect of COVID‑19 on first-time acute stroke and transient ischemic attack admission rates and prognosis in Denmark: a nationwide cohort study. Circulation 142:1227–1229" href="/article/10.1007/s00115-021-01104-1#ref-CR6" id="ref-link-section-d39729855e1119">6</a>]. Die Krankenhausmortalität bei den aufgenommenen Schlaganfallpatienten unterschied sich nicht signifikant zwischen der Lockdownperiode und den Vergleichszeiträumen.</p><blockquote class="c-blockquote c-blockquote--right"><div class="c-blockquote__body"><p>“Patienten mit leichtem Schlaganfall oder TIA stellten sich weniger häufig im Krankenhaus vor”
                            </p></div></blockquote><p>Aus Deutschland gab es die ersten Berichte anhand von Versicherungsdaten der Barmer Versicherung und aus dem bayrischen TEMPiS-Teleschlaganfall-Netzwerk. In der Analyse der Versicherungsdaten aus dem Zeitraum 01.01. bis 31.05.2020 zeigten sich verminderte Aufnahmeraten von TIA- und Schlaganfallpatienten und eine erhöhte Krankenhaussterblichkeit bei Schlaganfallpatienten (9,8 vs. 8,5 %) gegenüber dem gleichen Zeitraum im Jahr 2019 [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 30" title="Seiffert M, Brunner FJ, Remmel M et al (2020) Temporal trends in the presentation of cardiovascular and cerebrovascular emergencies during the COVID‑19 pandemic in Germany: an analysis of health insurance claims. Clin Res Cardiol 109:1540–1548" href="/article/10.1007/s00115-021-01104-1#ref-CR30" id="ref-link-section-d39729855e1128">30</a>]. Im TEMPiS Netzwerk gingen die Empfehlungen zum Einsatz einer intravenösen Thrombolyse bei akuten ischämischen Schlaganfallpatienten nach dem Lockdown Mitte März 2020 im Vergleich zu den 3 vorherigen Jahren zurück [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 29" title="Schlachetzki F, Theek C, Hubert ND et al (2020) Low stroke incidence in the TEMPiS telestroke network during COVID‑19 pandemic – effect of lockdown on thrombolysis and thrombectomy. J Telemed Telecare. &#xA;                  https://doi.org/10.1177/1357633X20943327&#xA;                  &#xA;                " href="/article/10.1007/s00115-021-01104-1#ref-CR29" id="ref-link-section-d39729855e1131">29</a>]. Die Rate der mechanischen Thrombektomien fiel nach dem Lockdown (7,6 %) auf das Niveau der Jahre 2017 bis 2019. Mittels einer Analyse der deutschlandweiten DESTATIS-Abrechnungsdaten konnten Richter und Kollegen zeigen, dass in den 2 Monaten des ersten COVID‑19-bedingten Lockdowns in Deutschland die stationären Aufnahmen von TIA-Patienten im Vergleich zu den beiden Vormonaten um 23 %, die von ischämischen Schlaganfällen um 17,4 % zurückgingen [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 25" title="Polack FP, Thomas SJ, Kitchin N et al (2020) Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 383:2603–2615" href="/article/10.1007/s00115-021-01104-1#ref-CR25" id="ref-link-section-d39729855e1134">25</a>]. Dementsprechend kam es zu einer Abnahme der Absolutzahlen der rekanalisierenden Akuttherapien bei ischämischen Schlaganfallpatienten. Die relative Thrombolyserate blieb während des Lockdowns mit 16,5 % aber unverändert, der Anteil der mechanisch thrombektomierten Patienten nahm deutschlandweit im Gegensatz zu den regionalen Zahlen aus TEMPiS sogar leicht während des Lockdowns zu (8,1 vs. 7,7 %). Dies ist wohl damit zu begründen, dass schwerer betroffene Schlaganfallpatienten mit einem großen Gefäßverschluss weiterhin ins Krankenhaus kamen, während sich Patienten mit einem leichteren („Minor“-)Schlaganfall oder einer TIA aus Angst vor einer SARS-CoV-2-Ansteckung weniger häufig im Krankenhaus vorstellten. Ebenso zeigen Triagedaten einer großen neurologischen Notaufnahme eine Abnahme in den nichtdringlichen Triagestufen, bei gleichzeitig stabiler Anzahl an Patienten der dringlichsten Triagestufe [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 20" title="Millan M, Nagel S, Gumbinger C et al (2020) Differential effects of the SARS-CoV‑2 pandemic on patients presenting to a neurological emergency room depending on their triage score in an area with low COVID‑19 incidence. Eur J Neurol. &#xA;                  https://doi.org/10.1111/ene.14709&#xA;                  &#xA;                " href="/article/10.1007/s00115-021-01104-1#ref-CR20" id="ref-link-section-d39729855e1137">20</a>]. Dafür spricht auch die während der 2‑monatigen 1. Welle um 1 % höhere Krankenhausmortalität ischämischer Schlaganfallpatienten im Vergleich zu Januar/Februar 2020 und dem entsprechenden Zeitraum im Jahr 2019.</p><blockquote class="c-blockquote c-blockquote--right"><div class="c-blockquote__body"><p>“Nicht alle Schlaganfallpatienten erhielten in ihren Zentren die sonst übliche Versorgung”
                            </p></div></blockquote><p>Die stabilen Lyse- und Thrombektomieraten in Deutschland während der COVID-Pandemie im Frühjahr sind wahrscheinlich Folge der im Vergleich zu anderen europäischen Ländern deutlich milder verlaufenden ersten Krankheitswelle und der weniger beeinträchtigten Notfall- und Schlaganfallversorgung. Sie sind auch der hohen Anzahl an Stroke-Unit- und Intensivbetten in deutschen Krankenhäusern zu verdanken [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 4" title="Bersano A, Kraemer M, Touze E et al (2020) Stroke care during the COVID‑19 pandemic: experience from three large European countries. Eur J Neurol 27:1794–1800" href="/article/10.1007/s00115-021-01104-1#ref-CR4" id="ref-link-section-d39729855e1147">4</a>]. In Frankreich und Spanien zeigte sich in schwer betroffenen Regionen eine deutliche Zunahme der „Door-to-needle“-Zeit bei der intravenösen Thrombolyse bzw. der „Bild-zu-Leistenpunktionszeit“ bei der mechanischen Thrombektomie [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 14" title="Kerleroux B, Fabacher T, Bricout N et al (2020) Mechanical thrombectomy for acute ischemic stroke amid the COVID‑19 outbreak: decreased activity, and increased care delays. Stroke 51:2012–2017" href="/article/10.1007/s00115-021-01104-1#ref-CR14" id="ref-link-section-d39729855e1150">14</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 32" title="Tejada Meza H, Lambea GA, Saldana SA et al (2020) Impact of COVID‑19 outbreak in reperfusion therapies of acute ischaemic stroke in northwest Spain. Eur J Neurol 27:2491–2498" href="/article/10.1007/s00115-021-01104-1#ref-CR32" id="ref-link-section-d39729855e1153">32</a>]. In einer Umfrage der European Stroke Organisation, auf die 426 Schlaganfallexperten aus 55 Ländern antworteten, wurden von 77 % der teilnehmenden europäischen Kollegen berichtet, dass nicht alle Schlaganfallpatienten die sonst übliche Versorgung in ihren Zentren erhalten konnten [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="Aguiar De Sousa D, Van Der Worp HB, Caso V et al (2020) Maintaining stroke care in Europe during the COVID‑19 pandemic: Results from an international survey of stroke professionals and practice recommendations from the European Stroke Organisation. Eur Stroke J 5:230–236" href="/article/10.1007/s00115-021-01104-1#ref-CR1" id="ref-link-section-d39729855e1156">1</a>]. Dies betraf sowohl die Schlaganfallakutversorgung als auch die Rehabilitation.</p></div></div></section><section data-title="Schlussfolgerungen"><div class="c-article-section" id="Sec6-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec6">Schlussfolgerungen</h2><div class="c-article-section__content" id="Sec6-content"><p>Angesichts der Neuheit der Erkrankung und der methodischen Limitationen der bisherigen Studien sollten die dargestellten Erkenntnisse zur Assoziation von COVID‑19 und Schlaganfällen als vorläufig betrachtet werden. Dennoch zeichnet sich ab, dass Schlaganfälle ebenso wie andere neurologische Komplikationen zum Spektrum der Manifestationen der COVID‑19-Erkrankung gehören. Da bei COVID‑19 häufig erst im Verlauf Schlaganfälle auftreten, sind ein klinisch-neurologisches Monitoring und die niedrigschwellige Veranlassung bildgebender Diagnostik bei Infizierten angezeigt. Eine generelle Primärprophylaxe von Schlaganfällen bei mit SARS-CoV-2-Infizierten – in Analogie zur Prävention venöser Thrombembolien – zeichnet sich derzeit noch nicht ab. Bei akuten ischämischen Schlaganfällen sollten die etablierten rekanalisierenden Therapien unter Berücksichtigung hygienischer Schutzmaßnahmen erfolgen und die weitere Betreuung gegebenenfalls auf monitorierten Isolierstationen unter Einbeziehung des Schlaganfallteams fortgeführt werden. Die Sekundärprävention nach einem ischämischen Schlaganfall folgt bislang den üblichen Vorgaben, wobei die ätiologische Diagnostik ungewöhnliche Mechanismen der Schlaganfallpathogenese und insbesondere auch eine Analyse von Thrombophilieparametern einbeziehen sollte. Aktuelle Empfehlungen für die Diagnose und Behandlung gibt die Deutsche Gesellschaft für Neurologie gemeinsam mit anderen Fachgesellschaften in der S1-Leitlinie „Neurologische Manifestationen bei COVID‑19.“ Die Effekte der Pandemie auf die längerfristige Sekundärprävention nach einem Schlaganfall sind naheliegend, aber bislang kaum untersucht.</p><p>Bei aller angemessenen Aufmerksamkeit für die COVID‑19-Pandemie darf die Behandlung nichtinfektiöser Entitäten wie Herz-Kreislauf‑, Schlaganfall- und Krebserkrankungen nicht vernachlässigt werden. Die erheblichen „Kollateralschäden“ für die klinische Schlaganfallforschung während der Pandemie, die Folge der Streichung oder Verlagerung personeller, ökonomischer und administrativer Ressourcen sowie der Kontaktbeschränkungen in 2020 war, dürfen sich in Zukunft nicht fortsetzen.</p></div></div></section><section data-title="Fazit für die Praxis"><div class="c-article-section" id="Sec7-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec7">Fazit für die Praxis</h2><div class="c-article-section__content" id="Sec7-content">
                <ul class="u-list-style-dash">
                  <li>
                    <p>Mit SARS-CoV‑2 („severe acute respiratory syndrome coronavirus 2“) infizierte Patienten scheinen ein gering erhöhtes Schlaganfallrisiko zu haben.</p>
                  </li>
                  <li>
                    <p>Die Mehrzahl COVID‑19(„coronavirus disease 2019“)-assoziierter ischämischer Schlaganfälle ist embolisch, verschließt große intrakranielle Gefäße, betrifft multiple Gefäßterritorien und verläuft schwerer. Die Emboliequelle bleibt bei mehr als 40 % unerkannt.</p>
                  </li>
                  <li>
                    <p>Obwohl bei SARS-CoV-2-Infizierten auch Hirnblutungen beschrieben wurden, ist unklar, ob es sich um eine Koinzidenz oder um einen pathogenetischen Zusammenhang handelt.</p>
                  </li>
                  <li>
                    <p>COVID‑19-positive Schlaganfallpatienten waren in Metaanalysen internationaler Studien signifikant jünger als nichtinfizierte Patienten.</p>
                  </li>
                  <li>
                    <p>Die Krankenhausmortalität war bei COVID‑19-positiven Schlaganfallpatienten in einigen Arbeiten gegenüber nichtinfizierten Patienten deutlich erhöht und liegt weltweit bei ca. einem Drittel.</p>
                  </li>
                  <li>
                    <p>COVID‑19-Patienten sollten hinsichtlich der Entwicklung von Schlaganfällen überwacht werden. Die Diagnostik sollte auch ungewöhnliche Ursachen in Betracht ziehen.</p>
                  </li>
                </ul>
              </div></div></section>
                        
                    

                    <div id="MagazineFulltextArticleBodySuffix"><section aria-labelledby="Bib1" data-title="Literatur"><div class="c-article-section" id="Bib1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Bib1">Literatur</h2><div class="c-article-section__content" id="Bib1-content"><div data-container-section="references"><ol class="c-article-references"><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">1.</span><p class="c-article-references__text" id="ref-CR1">Aguiar De Sousa D, Van Der Worp HB, Caso V et al (2020) Maintaining stroke care in Europe during the COVID‑19 pandemic: Results from an international survey of stroke professionals and practice recommendations from the European Stroke Organisation. Eur Stroke J 5:230–236</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1177%2F2396987320933746" aria-label="Article reference 1">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 1" href="http://scholar.google.com/scholar_lookup?&amp;title=Maintaining%20stroke%20care%20in%20Europe%20during%20the%20COVID%E2%80%9119%20pandemic%3A%20Results%20from%20an%20international%20survey%20of%20stroke%20professionals%20and%20practice%20recommendations%20from%20the%20European%20Stroke%20Organisation&amp;journal=Eur%20Stroke%20J&amp;volume=5&amp;pages=230-236&amp;publication_year=2020&amp;author=Aguiar%20De%20Sousa%2CD&amp;author=Der%20Worp%2CHB&amp;author=Caso%2CV">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">2.</span><p class="c-article-references__text" id="ref-CR2">Baldini T, Asioli GM, Romoli M et al (2021) Cerebral venous thrombosis and severe acute respiratory syndrome coronavirus‑2 infection: a systematic review and meta-analysis. Eur J Neurol. <a href="https://doi.org/10.1111/ene.14727">https://doi.org/10.1111/ene.14727</a></p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">3.</span><p class="c-article-references__text" id="ref-CR3">Bekelis K, Missios S, Ahmad J et al (2020) Ischemic stroke occurs less frequently in patients with COVID‑19: a multicenter cross-sectional study. Stroke 51:3570–3576</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BB3cXisVKgtL%252FO" aria-label="CAS reference 3">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1161%2FSTROKEAHA.120.031217" aria-label="Article reference 3">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 3" href="http://scholar.google.com/scholar_lookup?&amp;title=Ischemic%20stroke%20occurs%20less%20frequently%20in%20patients%20with%20COVID%E2%80%9119%3A%20a%20multicenter%20cross-sectional%20study&amp;journal=Stroke&amp;volume=51&amp;pages=3570-3576&amp;publication_year=2020&amp;author=Bekelis%2CK&amp;author=Missios%2CS&amp;author=Ahmad%2CJ">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">4.</span><p class="c-article-references__text" id="ref-CR4">Bersano A, Kraemer M, Touze E et al (2020) Stroke care during the COVID‑19 pandemic: experience from three large European countries. Eur J Neurol 27:1794–1800</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1%3ASTN%3A280%3ADC%252BB38rltlCisA%253D%253D" aria-label="CAS reference 4">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1111%2Fene.14375" aria-label="Article reference 4">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 4" href="http://scholar.google.com/scholar_lookup?&amp;title=Stroke%20care%20during%20the%20COVID%E2%80%9119%20pandemic%3A%20experience%20from%20three%20large%20European%20countries&amp;journal=Eur%20J%20Neurol&amp;volume=27&amp;pages=1794-1800&amp;publication_year=2020&amp;author=Bersano%2CA&amp;author=Kraemer%2CM&amp;author=Touze%2CE">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">5.</span><p class="c-article-references__text" id="ref-CR5">Boehme AK, Luna J, Kulick ER et al (2018) Influenza-like illness as a trigger for ischemic stroke. Ann Clin Transl Neurol 5:456–463</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1002%2Facn3.545" aria-label="Article reference 5">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 5" href="http://scholar.google.com/scholar_lookup?&amp;title=Influenza-like%20illness%20as%20a%C2%A0trigger%20for%20ischemic%20stroke&amp;journal=Ann%20Clin%20Transl%20Neurol&amp;volume=5&amp;pages=456-463&amp;publication_year=2018&amp;author=Boehme%2CAK&amp;author=Luna%2CJ&amp;author=Kulick%2CER">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">6.</span><p class="c-article-references__text" id="ref-CR6">Butt JH, Fosbol EL, Ostergaard L et al (2020) Effect of COVID‑19 on first-time acute stroke and transient ischemic attack admission rates and prognosis in Denmark: a nationwide cohort study. Circulation 142:1227–1229</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BB3cXitFaisL3M" aria-label="CAS reference 6">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1161%2FCIRCULATIONAHA.120.050173" aria-label="Article reference 6">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 6" href="http://scholar.google.com/scholar_lookup?&amp;title=Effect%20of%20COVID%E2%80%9119%20on%20first-time%20acute%20stroke%20and%20transient%20ischemic%20attack%20admission%20rates%20and%20prognosis%20in%20Denmark%3A%20a%20nationwide%20cohort%20study&amp;journal=Circulation&amp;volume=142&amp;pages=1227-1229&amp;publication_year=2020&amp;author=Butt%2CJH&amp;author=Fosbol%2CEL&amp;author=Ostergaard%2CL">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">7.</span><p class="c-article-references__text" id="ref-CR7">Cheng R, Leedy D (2020) COVID‑19 and acute myocardial injury: the heart of the matter or an innocent bystander? Heart 106:1122–1124</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BB3cXitlSit7jK" aria-label="CAS reference 7">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1136%2Fheartjnl-2020-317025" aria-label="Article reference 7">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 7" href="http://scholar.google.com/scholar_lookup?&amp;title=COVID%E2%80%9119%20and%20acute%20myocardial%20injury%3A%20the%20heart%20of%20the%20matter%20or%20an%20innocent%20bystander%3F&amp;journal=Heart&amp;volume=106&amp;pages=1122-1124&amp;publication_year=2020&amp;author=Cheng%2CR&amp;author=Leedy%2CD">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">8.</span><p class="c-article-references__text" id="ref-CR8">Field TS, Zhu H, Tarrant M et al (2004) Relationship between supra-annual trends in influenza rates and stroke occurrence. Neuroepidemiology 23:228–235</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1159%2F000079948" aria-label="Article reference 8">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 8" href="http://scholar.google.com/scholar_lookup?&amp;title=Relationship%20between%20supra-annual%20trends%20in%20influenza%20rates%20and%20stroke%20occurrence&amp;journal=Neuroepidemiology&amp;volume=23&amp;pages=228-235&amp;publication_year=2004&amp;author=Field%2CTS&amp;author=Zhu%2CH&amp;author=Tarrant%2CM">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">9.</span><p class="c-article-references__text" id="ref-CR9">Fridman S, Bres Bullrich M, Jimenez-Ruiz A et al (2020) Stroke risk, phenotypes, and death in COVID‑19: systematic review and newly reported cases. Neurology 95:e3373–e3385</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1212%2FWNL.0000000000010851" aria-label="Article reference 9">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 9" href="http://scholar.google.com/scholar_lookup?&amp;title=Stroke%20risk%2C%20phenotypes%2C%20and%20death%20in%20COVID%E2%80%9119%3A%20systematic%20review%20and%20newly%20reported%20cases&amp;journal=Neurology&amp;volume=95&amp;pages=e3373-e3385&amp;publication_year=2020&amp;author=Fridman%2CS&amp;author=Bres%20Bullrich%2CM&amp;author=Jimenez-Ruiz%2CA">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">10.</span><p class="c-article-references__text" id="ref-CR10">Hess DC, Eldahshan W, Rutkowski E (2020) COVID‑19-related stroke. Transl Stroke Res 11:322–325</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BB3cXovVOlsLk%253D" aria-label="CAS reference 10">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1007%2Fs12975-020-00818-9" aria-label="Article reference 10">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 10" href="http://scholar.google.com/scholar_lookup?&amp;title=COVID%E2%80%9119-related%20stroke&amp;journal=Transl%20Stroke%20Res&amp;volume=11&amp;pages=322-325&amp;publication_year=2020&amp;author=Hess%2CDC&amp;author=Eldahshan%2CW&amp;author=Rutkowski%2CE">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">11.</span><p class="c-article-references__text" id="ref-CR11">Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497–506</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BB3cXhs1Kqu7c%253D" aria-label="CAS reference 11">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2FS0140-6736%2820%2930183-5" aria-label="Article reference 11">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 11" href="http://scholar.google.com/scholar_lookup?&amp;title=Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan%2C%20China&amp;journal=Lancet&amp;volume=395&amp;pages=497-506&amp;publication_year=2020&amp;author=Huang%2CC&amp;author=Wang%2CY&amp;author=Li%2CX">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">12.</span><p class="c-article-references__text" id="ref-CR12">Iba T, Levy JH, Warkentin TE et al (2019) Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation. J Thromb Haemost 17:1989–1994</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BC1MXitVKqurvO" aria-label="CAS reference 12">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1111%2Fjth.14578" aria-label="Article reference 12">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 12" href="http://scholar.google.com/scholar_lookup?&amp;title=Diagnosis%20and%20management%20of%20sepsis-induced%20coagulopathy%20and%20disseminated%20intravascular%20coagulation&amp;journal=J%20Thromb%20Haemost&amp;volume=17&amp;pages=1989-1994&amp;publication_year=2019&amp;author=Iba%2CT&amp;author=Levy%2CJH&amp;author=Warkentin%2CTE">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">13.</span><p class="c-article-references__text" id="ref-CR13">July J, Pranata R (2020) Impact of the Coronavirus disease pandemic on the number of strokes and mechanical thrombectomies: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis 29:105185</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2Fj.jstrokecerebrovasdis.2020.105185" aria-label="Article reference 13">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 13" href="http://scholar.google.com/scholar_lookup?&amp;title=Impact%20of%20the%20Coronavirus%20disease%20pandemic%20on%20the%20number%20of%20strokes%20and%20mechanical%20thrombectomies%3A%20a%20systematic%20review%20and%20meta-analysis&amp;journal=J%20Stroke%20Cerebrovasc%20Dis&amp;volume=29&amp;publication_year=2020&amp;author=July%2CJ&amp;author=Pranata%2CR">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">14.</span><p class="c-article-references__text" id="ref-CR14">Kerleroux B, Fabacher T, Bricout N et al (2020) Mechanical thrombectomy for acute ischemic stroke amid the COVID‑19 outbreak: decreased activity, and increased care delays. Stroke 51:2012–2017</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BB3cXhslGitb7J" aria-label="CAS reference 14">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1161%2FSTROKEAHA.120.030373" aria-label="Article reference 14">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 14" href="http://scholar.google.com/scholar_lookup?&amp;title=Mechanical%20thrombectomy%20for%20acute%20ischemic%20stroke%20amid%20the%20COVID%E2%80%9119%20outbreak%3A%20decreased%20activity%2C%20and%20increased%20care%20delays&amp;journal=Stroke&amp;volume=51&amp;pages=2012-2017&amp;publication_year=2020&amp;author=Kerleroux%2CB&amp;author=Fabacher%2CT&amp;author=Bricout%2CN">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">15.</span><p class="c-article-references__text" id="ref-CR15">Lavallee PC, Labreuche J, Fox KM et al (2014) Influenza vaccination and cardiovascular risk in patients with recent TIA and stroke. Neurology 82:1905–1913</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BC2cXovFalsrc%253D" aria-label="CAS reference 15">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1212%2FWNL.0000000000000456" aria-label="Article reference 15">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 15" href="http://scholar.google.com/scholar_lookup?&amp;title=Influenza%20vaccination%20and%20cardiovascular%20risk%20in%20patients%20with%20recent%20TIA%20and%20stroke&amp;journal=Neurology&amp;volume=82&amp;pages=1905-1913&amp;publication_year=2014&amp;author=Lavallee%2CPC&amp;author=Labreuche%2CJ&amp;author=Fox%2CKM">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">16.</span><p class="c-article-references__text" id="ref-CR16">Lee KR, Bae JH, Hwang IC et al (2017) Effect of influenza vaccination on risk of stroke: a systematic review and meta-analysis. Neuroepidemiology 48:103–110</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1159%2F000478017" aria-label="Article reference 16">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 16" href="http://scholar.google.com/scholar_lookup?&amp;title=Effect%20of%20influenza%20vaccination%20on%20risk%20of%20stroke%3A%20a%20systematic%20review%20and%20meta-analysis&amp;journal=Neuroepidemiology&amp;volume=48&amp;pages=103-110&amp;publication_year=2017&amp;author=Lee%2CKR&amp;author=Bae%2CJH&amp;author=Hwang%2CIC">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">17.</span><p class="c-article-references__text" id="ref-CR17">Li Y, Li M, Wang M et al (2020) Acute cerebrovascular disease following COVID‑19: a single center, retrospective, observational study. Stroke Vasc Neurol 5:279–284</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1136%2Fsvn-2020-000431" aria-label="Article reference 17">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 17" href="http://scholar.google.com/scholar_lookup?&amp;title=Acute%20cerebrovascular%20disease%20following%20COVID%E2%80%9119%3A%20a%C2%A0single%20center%2C%20retrospective%2C%20observational%20study&amp;journal=Stroke%20Vasc%20Neurol&amp;volume=5&amp;pages=279-284&amp;publication_year=2020&amp;author=Li%2CY&amp;author=Li%2CM&amp;author=Wang%2CM">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">18.</span><p class="c-article-references__text" id="ref-CR18">Marchandot B, Sattler L, Jesel L et al (2020) COVID‑19 related Coagulopathy: a distinct entity? J Clin Med 31:1651</p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">19.</span><p class="c-article-references__text" id="ref-CR19">Merkler AE, Parikh NS, Mir S et al (2020) Risk of Ischemic stroke in patients with Coronavirus disease 2019 (COVID‑19) vs patients with influenza. JAMA Neurol 77:1–7</p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">20.</span><p class="c-article-references__text" id="ref-CR20">Millan M, Nagel S, Gumbinger C et al (2020) Differential effects of the SARS-CoV‑2 pandemic on patients presenting to a neurological emergency room depending on their triage score in an area with low COVID‑19 incidence. Eur J Neurol. <a href="https://doi.org/10.1111/ene.14709">https://doi.org/10.1111/ene.14709</a></p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">21.</span><p class="c-article-references__text" id="ref-CR21">Modin D, Claggett B, Sindet-Pedersen C et al (2020) Acute COVID‑19 and the incidence of Ischemic stroke and acute myocardial infarction. Circulation 142:2080–2082</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BB3cXisVyju7rL" aria-label="CAS reference 21">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1161%2FCIRCULATIONAHA.120.050809" aria-label="Article reference 21">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 21" href="http://scholar.google.com/scholar_lookup?&amp;title=Acute%20COVID%E2%80%9119%20and%20the%20incidence%20of%20Ischemic%20stroke%20and%20acute%20myocardial%20infarction&amp;journal=Circulation&amp;volume=142&amp;pages=2080-2082&amp;publication_year=2020&amp;author=Modin%2CD&amp;author=Claggett%2CB&amp;author=Sindet-Pedersen%2CC">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">22.</span><p class="c-article-references__text" id="ref-CR22">Nannoni S, De Groot R, Bell S et al (2021) Stroke in COVID‑19: a systematic review and meta-analysis. Int J Stroke 16:137–149</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1177%2F1747493020972922" aria-label="Article reference 22">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 22" href="http://scholar.google.com/scholar_lookup?&amp;title=Stroke%20in%20COVID%E2%80%9119%3A%20a%20systematic%20review%20and%20meta-analysis&amp;journal=Int%20J%20Stroke&amp;volume=16&amp;pages=137-149&amp;publication_year=2021&amp;author=Nannoni%2CS&amp;author=Groot%2CR&amp;author=Bell%2CS">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">23.</span><p class="c-article-references__text" id="ref-CR23">Oxley TJ, Mocco J, Majidi S et al (2020) Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med 382:e60</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1056%2FNEJMc2009787" aria-label="Article reference 23">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 23" href="http://scholar.google.com/scholar_lookup?&amp;title=Large-vessel%20stroke%20as%20a%C2%A0presenting%20feature%20of%20Covid-19%20in%20the%20young&amp;journal=N%20Engl%20J%20Med&amp;volume=382&amp;publication_year=2020&amp;author=Oxley%2CTJ&amp;author=Mocco%2CJ&amp;author=Majidi%2CS">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">24.</span><p class="c-article-references__text" id="ref-CR24">Perry RJ, Smith CJ, Roffe C et al (2020) Characteristics and outcomes of COVID‑19 associated stroke: a UK multicentre case-control study. J Neurol Neurosurg Psychiatry 92:242–248</p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">25.</span><p class="c-article-references__text" id="ref-CR25">Polack FP, Thomas SJ, Kitchin N et al (2020) Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 383:2603–2615</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BB3MXotFSjuw%253D%253D" aria-label="CAS reference 25">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1056%2FNEJMoa2034577" aria-label="Article reference 25">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 25" href="http://scholar.google.com/scholar_lookup?&amp;title=Safety%20and%20efficacy%20of%20the%20BNT162b2%20mRNA%20Covid-19%20vaccine&amp;journal=N%20Engl%20J%20Med&amp;volume=383&amp;pages=2603-2615&amp;publication_year=2020&amp;author=Polack%2CFP&amp;author=Thomas%2CSJ&amp;author=Kitchin%2CN">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">26.</span><p class="c-article-references__text" id="ref-CR26">Qureshi AI, Baskett WI, Huang W et al (2021) Acute Ischemic stroke and COVID‑19: an analysis of 27 676 patients. Stroke. <a href="https://doi.org/10.1161/STROKEAHA.120.031786">https://doi.org/10.1161/STROKEAHA.120.031786</a></p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">27.</span><p class="c-article-references__text" id="ref-CR27">Richter D, Bartig D, Krogias C et al (2020) Letter to the editor: risk comorbidities of COVID‑19 in Parkinson′s disease patients in Germany. Neurol Res Pract 2:22</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1186%2Fs42466-020-00069-x" aria-label="Article reference 27">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 27" href="http://scholar.google.com/scholar_lookup?&amp;title=Letter%20to%20the%20editor%3A%20risk%20comorbidities%20of%20COVID%E2%80%9119%20in%20Parkinson%E2%80%B2s%20disease%20patients%20in%20Germany&amp;journal=Neurol%20Res%20Pract&amp;volume=2&amp;publication_year=2020&amp;author=Richter%2CD&amp;author=Bartig%2CD&amp;author=Krogias%2CC">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">28.</span><p class="c-article-references__text" id="ref-CR28">Richter D, Krogias C, Eyding J et al (2020) Comparison of stroke care parameters in acute ischemic stroke patients with and without concurrent Covid-19. A Nationwide analysis. Neurol Res Pract 2:48</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1186%2Fs42466-020-00095-9" aria-label="Article reference 28">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 28" href="http://scholar.google.com/scholar_lookup?&amp;title=Comparison%20of%20stroke%20care%20parameters%20in%20acute%20ischemic%20stroke%20patients%20with%20and%20without%20concurrent%20Covid-19.%20A%20Nationwide%20analysis&amp;journal=Neurol%20Res%20Pract&amp;volume=2&amp;publication_year=2020&amp;author=Richter%2CD&amp;author=Krogias%2CC&amp;author=Eyding%2CJ">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">29.</span><p class="c-article-references__text" id="ref-CR29">Schlachetzki F, Theek C, Hubert ND et al (2020) Low stroke incidence in the TEMPiS telestroke network during COVID‑19 pandemic – effect of lockdown on thrombolysis and thrombectomy. J Telemed Telecare. <a href="https://doi.org/10.1177/1357633X20943327">https://doi.org/10.1177/1357633X20943327</a></p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">30.</span><p class="c-article-references__text" id="ref-CR30">Seiffert M, Brunner FJ, Remmel M et al (2020) Temporal trends in the presentation of cardiovascular and cerebrovascular emergencies during the COVID‑19 pandemic in Germany: an analysis of health insurance claims. Clin Res Cardiol 109:1540–1548</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1007%2Fs00392-020-01723-9" aria-label="Article reference 30">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 30" href="http://scholar.google.com/scholar_lookup?&amp;title=Temporal%20trends%20in%20the%20presentation%20of%20cardiovascular%20and%20cerebrovascular%20emergencies%20during%20the%20COVID%E2%80%9119%20pandemic%20in%20Germany%3A%20an%20analysis%20of%20health%20insurance%20claims&amp;journal=Clin%20Res%20Cardiol&amp;volume=109&amp;pages=1540-1548&amp;publication_year=2020&amp;author=Seiffert%2CM&amp;author=Brunner%2CFJ&amp;author=Remmel%2CM">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">31.</span><p class="c-article-references__text" id="ref-CR31">South K, Mcculloch L, Mccoll BW et al (2020) Preceding infection and risk of stroke: an old concept revived by the COVID‑19 pandemic. Int J Stroke 15:722–732</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1177%2F1747493020943815" aria-label="Article reference 31">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 31" href="http://scholar.google.com/scholar_lookup?&amp;title=Preceding%20infection%20and%20risk%20of%20stroke%3A%20an%20old%20concept%20revived%20by%20the%20COVID%E2%80%9119%20pandemic&amp;journal=Int%20J%20Stroke&amp;volume=15&amp;pages=722-732&amp;publication_year=2020&amp;author=South%2CK&amp;author=Mcculloch%2CL&amp;author=Mccoll%2CBW">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">32.</span><p class="c-article-references__text" id="ref-CR32">Tejada Meza H, Lambea GA, Saldana SA et al (2020) Impact of COVID‑19 outbreak in reperfusion therapies of acute ischaemic stroke in northwest Spain. Eur J Neurol 27:2491–2498</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1%3ASTN%3A280%3ADC%252BB38fitFGmtQ%253D%253D" aria-label="CAS reference 32">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1111%2Fene.14467" aria-label="Article reference 32">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 32" href="http://scholar.google.com/scholar_lookup?&amp;title=Impact%20of%20COVID%E2%80%9119%20outbreak%20in%20reperfusion%20therapies%20of%20acute%20ischaemic%20stroke%20in%20northwest%20Spain&amp;journal=Eur%20J%20Neurol&amp;volume=27&amp;pages=2491-2498&amp;publication_year=2020&amp;author=Tejada%20Meza%2CH&amp;author=Lambea%2CGA&amp;author=Saldana%2CSA">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">33.</span><p class="c-article-references__text" id="ref-CR33">Toschke AM, Heuschmann PU, Wood O et al (2009) Temporal relationship between influenza infections and subsequent first-ever stroke incidence. Age Ageing 38:100–103</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1093%2Fageing%2Fafn232" aria-label="Article reference 33">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 33" href="http://scholar.google.com/scholar_lookup?&amp;title=Temporal%20relationship%20between%20influenza%20infections%20and%20subsequent%20first-ever%20stroke%20incidence&amp;journal=Age%20Ageing&amp;volume=38&amp;pages=100-103&amp;publication_year=2009&amp;author=Toschke%2CAM&amp;author=Heuschmann%2CPU&amp;author=Wood%2CO">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">34.</span><p class="c-article-references__text" id="ref-CR34">Tsivgoulis G, Palaiodimou L, Zand R et al (2020) COVID‑19 and cerebrovascular diseases: a comprehensive overview. Ther Adv Neurol Disord 13:1756286420978004</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BB3MXjtVGlsQ%253D%253D" aria-label="CAS reference 34">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33343709" aria-label="PubMed reference 34" rel="nofollow">PubMed</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727052" aria-label="PubMed Central reference 34" rel="nofollow">PubMed Central</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 34" href="http://scholar.google.com/scholar_lookup?&amp;title=COVID%E2%80%9119%20and%20cerebrovascular%20diseases%3A%20a%C2%A0comprehensive%20overview&amp;journal=Ther%20Adv%20Neurol%20Disord&amp;volume=13&amp;publication_year=2020&amp;author=Tsivgoulis%2CG&amp;author=Palaiodimou%2CL&amp;author=Zand%2CR">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">35.</span><p class="c-article-references__text" id="ref-CR35">Udell JA, Zawi R, Bhatt DL et al (2013) Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA 310:1711–1720</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BC3sXhvVahs7nL" aria-label="CAS reference 35">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1001%2Fjama.2013.279206" aria-label="Article reference 35">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 35" href="http://scholar.google.com/scholar_lookup?&amp;title=Association%20between%20influenza%20vaccination%20and%20cardiovascular%20outcomes%20in%20high-risk%20patients%3A%20a%C2%A0meta-analysis&amp;journal=JAMA&amp;volume=310&amp;pages=1711-1720&amp;publication_year=2013&amp;author=Udell%2CJA&amp;author=Zawi%2CR&amp;author=Bhatt%2CDL">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">36.</span><p class="c-article-references__text" id="ref-CR36">Varga Z, Flammer AJ, Steiger P et al (2020) Endothelial cell infection and endotheliitis in COVID‑19. Lancet 395:1417–1418</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BB3cXnslektbs%253D" aria-label="CAS reference 36">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2FS0140-6736%2820%2930937-5" aria-label="Article reference 36">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 36" href="http://scholar.google.com/scholar_lookup?&amp;title=Endothelial%20cell%20infection%20and%20endotheliitis%20in%20COVID%E2%80%9119&amp;journal=Lancet&amp;volume=395&amp;pages=1417-1418&amp;publication_year=2020&amp;author=Varga%2CZ&amp;author=Flammer%2CAJ&amp;author=Steiger%2CP">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">37.</span><p class="c-article-references__text" id="ref-CR37">Warren-Gash C, Blackburn R, Whitaker H et al (2018) Laboratory-confirmed respiratory infections as triggers for acute myocardial infarction and stroke: a self-controlled case series analysis of national linked datasets from Scotland. Eur Respir J. <a href="https://doi.org/10.1183/13993003.01794-2017">https://doi.org/10.1183/13993003.01794-2017</a></p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">38.</span><p class="c-article-references__text" id="ref-CR38">Zhang Y, Xiao M, Zhang S et al (2020) Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med 382:e38</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1056%2FNEJMc2007575" aria-label="Article reference 38">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 38" href="http://scholar.google.com/scholar_lookup?&amp;title=Coagulopathy%20and%20antiphospholipid%20antibodies%20in%20patients%20with%20Covid-19&amp;journal=N%20Engl%20J%20Med&amp;volume=382&amp;publication_year=2020&amp;author=Zhang%2CY&amp;author=Xiao%2CM&amp;author=Zhang%2CS">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item"><span class="c-article-references__counter">39.</span><p class="c-article-references__text" id="ref-CR39">Zhou P, Yang XL, Wang XG et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579:270–273</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BB3cXksFKlsLg%253D" aria-label="CAS reference 39">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fs41586-020-2012-7" aria-label="Article reference 39">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 39" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20pneumonia%20outbreak%20associated%20with%20a%C2%A0new%20coronavirus%20of%20probable%20bat%20origin&amp;journal=Nature&amp;volume=579&amp;pages=270-273&amp;publication_year=2020&amp;author=Zhou%2CP&amp;author=Yang%2CXL&amp;author=Wang%2CXG">
                    Google Scholar</a> 
                </p></li></ol><p class="c-article-references__download u-hide-print"><a data-track="click" data-track-action="download citation references" data-track-label="link" href="https://citation-needed.springer.com/v2/references/10.1007/s00115-021-01104-1?format=refman&amp;flavour=references">Download references<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-download"></use></svg></a></p></div></div></div></section></div><section><div class="c-article-section" id="Ack1-section"><div class="c-article-section__content" id="Ack1-content"></div></div></section><section data-title="Funding"><div class="c-article-section" id="Fun-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Fun">Funding</h2><div class="c-article-section__content" id="Fun-content"><p>Open access funding provided by Imperial College London.</p></div></div></section><section aria-labelledby="author-information" data-title="Author information"><div class="c-article-section" id="author-information-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="author-information">Author information</h2><div class="c-article-section__content" id="author-information-content"><h3 class="c-article__sub-heading" id="affiliations">Affiliations</h3><ol class="c-article-author-affiliation__list"><li id="Aff1"><p class="c-article-author-affiliation__address">Neurologische Klinik, Alfried Krupp Krankenhaus Essen, Alfried Krupp Str. 21, 45131, Essen, Deutschland</p><p class="c-article-author-affiliation__authors-list"> Roland Veltkamp &amp; Ralph Weber</p></li><li id="Aff2"><p class="c-article-author-affiliation__address">Department of Brain Sciences, Imperial College London, London, Großbritannien</p><p class="c-article-author-affiliation__authors-list"> Roland Veltkamp</p></li><li id="Aff3"><p class="c-article-author-affiliation__address">Neurologische Klinik, Universitätsklinikum Heidelberg, Heidelberg, Deutschland</p><p class="c-article-author-affiliation__authors-list"> Roland Veltkamp &amp; Jan C. Purrucker</p></li></ol><div class="u-js-hide u-hide-print" data-test="author-info"><span class="c-article__sub-heading">Authors</span><ol class="c-article-authors-search u-list-reset"><li id="auth-Roland-Veltkamp"><span class="c-article-authors-search__title u-h3 js-search-name"> Roland Veltkamp</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?dc.creator=&#34;Roland+Veltkamp&#34;" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text">You can also search for this author in
                        <span class="c-article-identifiers"><a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Roland+Veltkamp" data-track="click" data-track-action="author link - pubmed" data-track-label="link">PubMed</a><span class="u-hide"> </span><a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Roland+Veltkamp%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link">Google Scholar</a></span></p></div></div></li><li id="auth-Jan_C_-Purrucker"><span class="c-article-authors-search__title u-h3 js-search-name">Jan C. Purrucker</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?dc.creator=&#34;Jan C.+Purrucker&#34;" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text">You can also search for this author in
                        <span class="c-article-identifiers"><a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Jan C.+Purrucker" data-track="click" data-track-action="author link - pubmed" data-track-label="link">PubMed</a><span class="u-hide"> </span><a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Jan C.+Purrucker%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link">Google Scholar</a></span></p></div></div></li><li id="auth-Ralph-Weber"><span class="c-article-authors-search__title u-h3 js-search-name">Ralph Weber</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?dc.creator=&#34;Ralph+Weber&#34;" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text">You can also search for this author in
                        <span class="c-article-identifiers"><a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Ralph+Weber" data-track="click" data-track-action="author link - pubmed" data-track-label="link">PubMed</a><span class="u-hide"> </span><a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Ralph+Weber%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link">Google Scholar</a></span></p></div></div></li></ol></div><h3 class="c-article__sub-heading" id="corresponding-author">Corresponding author</h3><p id="corresponding-author-list">Correspondence to
                <span> Roland Veltkamp</span>.</p></div></div></section><section data-title="Ethics declarations"><div class="c-article-section" id="ethics-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="ethics">Ethics declarations</h2><div class="c-article-section__content" id="ethics-content">
              
              
                <h3 class="c-article__sub-heading" id="FPar1">Interessenkonflikt</h3>
                <p>R. Veltkamp ist koordinierender Projektleiter der PRESTIGE-AF-Studie, die von der Europäischen Kommission im Rahmen des HORIZON-2020-Programms (Grant agreement 754517) unterstützt wird, und hat Honorare für Beratungen, Vorträge und Unterstützung für Forschungsprojekte erhalten von Boehringer Ingelheim, Bayer, BMS, Pfizer, Daiichi Sankyo, Medtronic, Biogen, Astra Zeneca. J. C. Purrucker hat Honorare für Beratungen und Vorträge von Abbott, Akcea, Boehringer Ingelheim, Bayer, BMS Pfizer und Daiichi Sankyo erhalten. R. Weber hat Honorare für Vorträge von BMS und Medtronic erhalten.</p>
              
              <p>Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.</p>
            </div></div></section><section data-title="Rights and permissions"><div class="c-article-section" id="rightslink-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="rightslink">Rights and permissions</h2><div class="c-article-section__content" id="rightslink-content">
                <p><b>Open Access</b>  Dieser Artikel wird unter der Creative Commons Namensnennung 4.0 International Lizenz veröffentlicht, welche die Nutzung, Vervielfältigung, Bearbeitung, Verbreitung und Wiedergabe in jeglichem Medium und Format erlaubt, sofern Sie den/die ursprünglichen Autor(en) und die Quelle ordnungsgemäß nennen, einen Link zur Creative Commons Lizenz beifügen und angeben, ob Änderungen vorgenommen wurden.</p>
                <p>Die in diesem Artikel enthaltenen Bilder und sonstiges Drittmaterial unterliegen ebenfalls der genannten Creative Commons Lizenz, sofern sich aus der Abbildungslegende nichts anderes ergibt. Sofern das betreffende Material nicht unter der genannten Creative Commons Lizenz steht und die betreffende Handlung nicht nach gesetzlichen Vorschriften erlaubt ist, ist für die oben aufgeführten Weiterverwendungen des Materials die Einwilligung des jeweiligen Rechteinhabers einzuholen.</p>
                <p>Weitere Details zur Lizenz entnehmen Sie bitte der Lizenzinformation auf <a href="http://creativecommons.org/licenses/by/4.0/deed.de" rel="license" itemprop="license">http://creativecommons.org/licenses/by/4.0/deed.de</a>.</p>
              <p class="c-article-rights"><a data-track="click" data-track-action="view rights and permissions" data-track-label="link" href="https://s100.copyright.com/AppDispatchServlet?title=Neurovaskul%C3%A4re%20Manifestationen%20von%20COVID%E2%80%9119&amp;author=Prof.%20Dr.%20Roland%20Veltkamp%20et%20al&amp;contentID=10.1007%2Fs00115-021-01104-1&amp;copyright=The%20Author%28s%29&amp;publication=0028-2804&amp;publicationDate=2021-03-24&amp;publisherName=SpringerNature&amp;orderBeanReset=true&amp;oa=CC%20BY">Reprints and Permissions</a></p></div></div></section><section aria-labelledby="article-info" data-title="About this article"><div class="c-article-section" id="article-info-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="article-info">About this article</h2><div class="c-article-section__content" id="article-info-content"><div class="c-bibliographic-information"><div class="u-hide-print c-bibliographic-information__column c-bibliographic-information__column--border"><a data-crossmark="10.1007/s00115-021-01104-1" target="_blank" rel="noopener" href="https://crossmark.crossref.org/dialog/?doi=10.1007/s00115-021-01104-1" data-track="click" data-track-action="Click Crossmark" data-track-label="link" data-test="crossmark"><img width="57" height="81" alt="Verify currency and authenticity via CrossMark" src="data:image/svg+xml;base64,<svg height="81" width="57" xmlns="http://www.w3.org/2000/svg"><g fill="none" fill-rule="evenodd"><path d="m17.35 35.45 21.3-14.2v-17.03h-21.3" fill="#989898"/><path d="m38.65 35.45-21.3-14.2v-17.03h21.3" fill="#747474"/><path d="m28 .5c-12.98 0-23.5 10.52-23.5 23.5s10.52 23.5 23.5 23.5 23.5-10.52 23.5-23.5c0-6.23-2.48-12.21-6.88-16.62-4.41-4.4-10.39-6.88-16.62-6.88zm0 41.25c-9.8 0-17.75-7.95-17.75-17.75s7.95-17.75 17.75-17.75 17.75 7.95 17.75 17.75c0 4.71-1.87 9.22-5.2 12.55s-7.84 5.2-12.55 5.2z" fill="#535353"/><path d="m41 36c-5.81 6.23-15.23 7.45-22.43 2.9-7.21-4.55-10.16-13.57-7.03-21.5l-4.92-3.11c-4.95 10.7-1.19 23.42 8.78 29.71 9.97 6.3 23.07 4.22 30.6-4.86z" fill="#9c9c9c"/><path d="m.2 58.45c0-.75.11-1.42.33-2.01s.52-1.09.91-1.5c.38-.41.83-.73 1.34-.94.51-.22 1.06-.32 1.65-.32.56 0 1.06.11 1.51.35.44.23.81.5 1.1.81l-.91 1.01c-.24-.24-.49-.42-.75-.56-.27-.13-.58-.2-.93-.2-.39 0-.73.08-1.05.23-.31.16-.58.37-.81.66-.23.28-.41.63-.53 1.04-.13.41-.19.88-.19 1.39 0 1.04.23 1.86.68 2.46.45.59 1.06.88 1.84.88.41 0 .77-.07 1.07-.23s.59-.39.85-.68l.91 1c-.38.43-.8.76-1.28.99-.47.22-1 .34-1.58.34-.59 0-1.13-.1-1.64-.31-.5-.2-.94-.51-1.31-.91-.38-.4-.67-.9-.88-1.48-.22-.59-.33-1.26-.33-2.02zm8.4-5.33h1.61v2.54l-.05 1.33c.29-.27.61-.51.96-.72s.76-.31 1.24-.31c.73 0 1.27.23 1.61.71.33.47.5 1.14.5 2.02v4.31h-1.61v-4.1c0-.57-.08-.97-.25-1.21-.17-.23-.45-.35-.83-.35-.3 0-.56.08-.79.22-.23.15-.49.36-.78.64v4.8h-1.61zm7.37 6.45c0-.56.09-1.06.26-1.51.18-.45.42-.83.71-1.14.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.36c.07.62.29 1.1.65 1.44.36.33.82.5 1.38.5.29 0 .57-.04.83-.13s.51-.21.76-.37l.55 1.01c-.33.21-.69.39-1.09.53-.41.14-.83.21-1.26.21-.48 0-.92-.08-1.34-.25-.41-.16-.76-.4-1.07-.7-.31-.31-.55-.69-.72-1.13-.18-.44-.26-.95-.26-1.52zm4.6-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.07.45-.31.29-.5.73-.58 1.3zm2.5.62c0-.57.09-1.08.28-1.53.18-.44.43-.82.75-1.13s.69-.54 1.1-.71c.42-.16.85-.24 1.31-.24.45 0 .84.08 1.17.23s.61.34.85.57l-.77 1.02c-.19-.16-.38-.28-.56-.37-.19-.09-.39-.14-.61-.14-.56 0-1.01.21-1.35.63-.35.41-.52.97-.52 1.67 0 .69.17 1.24.51 1.66.34.41.78.62 1.32.62.28 0 .54-.06.78-.17.24-.12.45-.26.64-.42l.67 1.03c-.33.29-.69.51-1.08.65-.39.15-.78.23-1.18.23-.46 0-.9-.08-1.31-.24-.4-.16-.75-.39-1.05-.7s-.53-.69-.7-1.13c-.17-.45-.25-.96-.25-1.53zm6.91-6.45h1.58v6.17h.05l2.54-3.16h1.77l-2.35 2.8 2.59 4.07h-1.75l-1.77-2.98-1.08 1.23v1.75h-1.58zm13.69 1.27c-.25-.11-.5-.17-.75-.17-.58 0-.87.39-.87 1.16v.75h1.34v1.27h-1.34v5.6h-1.61v-5.6h-.92v-1.2l.92-.07v-.72c0-.35.04-.68.13-.98.08-.31.21-.57.4-.79s.42-.39.71-.51c.28-.12.63-.18 1.04-.18.24 0 .48.02.69.07.22.05.41.1.57.17zm.48 5.18c0-.57.09-1.08.27-1.53.17-.44.41-.82.72-1.13.3-.31.65-.54 1.04-.71.39-.16.8-.24 1.23-.24s.84.08 1.24.24c.4.17.74.4 1.04.71s.54.69.72 1.13c.19.45.28.96.28 1.53s-.09 1.08-.28 1.53c-.18.44-.42.82-.72 1.13s-.64.54-1.04.7-.81.24-1.24.24-.84-.08-1.23-.24-.74-.39-1.04-.7c-.31-.31-.55-.69-.72-1.13-.18-.45-.27-.96-.27-1.53zm1.65 0c0 .69.14 1.24.43 1.66.28.41.68.62 1.18.62.51 0 .9-.21 1.19-.62.29-.42.44-.97.44-1.66 0-.7-.15-1.26-.44-1.67-.29-.42-.68-.63-1.19-.63-.5 0-.9.21-1.18.63-.29.41-.43.97-.43 1.67zm6.48-3.44h1.33l.12 1.21h.05c.24-.44.54-.79.88-1.02.35-.24.7-.36 1.07-.36.32 0 .59.05.78.14l-.28 1.4-.33-.09c-.11-.01-.23-.02-.38-.02-.27 0-.56.1-.86.31s-.55.58-.77 1.1v4.2h-1.61zm-47.87 15h1.61v4.1c0 .57.08.97.25 1.2.17.24.44.35.81.35.3 0 .57-.07.8-.22.22-.15.47-.39.73-.73v-4.7h1.61v6.87h-1.32l-.12-1.01h-.04c-.3.36-.63.64-.98.86-.35.21-.76.32-1.24.32-.73 0-1.27-.24-1.61-.71-.33-.47-.5-1.14-.5-2.02zm9.46 7.43v2.16h-1.61v-9.59h1.33l.12.72h.05c.29-.24.61-.45.97-.63.35-.17.72-.26 1.1-.26.43 0 .81.08 1.15.24.33.17.61.4.84.71.24.31.41.68.53 1.11.13.42.19.91.19 1.44 0 .59-.09 1.11-.25 1.57-.16.47-.38.85-.65 1.16-.27.32-.58.56-.94.73-.35.16-.72.25-1.1.25-.3 0-.6-.07-.9-.2s-.59-.31-.87-.56zm0-2.3c.26.22.5.37.73.45.24.09.46.13.66.13.46 0 .84-.2 1.15-.6.31-.39.46-.98.46-1.77 0-.69-.12-1.22-.35-1.61-.23-.38-.61-.57-1.13-.57-.49 0-.99.26-1.52.77zm5.87-1.69c0-.56.08-1.06.25-1.51.16-.45.37-.83.65-1.14.27-.3.58-.54.93-.71s.71-.25 1.08-.25c.39 0 .73.07 1 .2.27.14.54.32.81.55l-.06-1.1v-2.49h1.61v9.88h-1.33l-.11-.74h-.06c-.25.25-.54.46-.88.64-.33.18-.69.27-1.06.27-.87 0-1.56-.32-2.07-.95s-.76-1.51-.76-2.65zm1.67-.01c0 .74.13 1.31.4 1.7.26.38.65.58 1.15.58.51 0 .99-.26 1.44-.77v-3.21c-.24-.21-.48-.36-.7-.45-.23-.08-.46-.12-.7-.12-.45 0-.82.19-1.13.59-.31.39-.46.95-.46 1.68zm6.35 1.59c0-.73.32-1.3.97-1.71.64-.4 1.67-.68 3.08-.84 0-.17-.02-.34-.07-.51-.05-.16-.12-.3-.22-.43s-.22-.22-.38-.3c-.15-.06-.34-.1-.58-.1-.34 0-.68.07-1 .2s-.63.29-.93.47l-.59-1.08c.39-.24.81-.45 1.28-.63.47-.17.99-.26 1.54-.26.86 0 1.51.25 1.93.76s.63 1.25.63 2.21v4.07h-1.32l-.12-.76h-.05c-.3.27-.63.48-.98.66s-.73.27-1.14.27c-.61 0-1.1-.19-1.48-.56-.38-.36-.57-.85-.57-1.46zm1.57-.12c0 .3.09.53.27.67.19.14.42.21.71.21.28 0 .54-.07.77-.2s.48-.31.73-.56v-1.54c-.47.06-.86.13-1.18.23-.31.09-.57.19-.76.31s-.33.25-.41.4c-.09.15-.13.31-.13.48zm6.29-3.63h-.98v-1.2l1.06-.07.2-1.88h1.34v1.88h1.75v1.27h-1.75v3.28c0 .8.32 1.2.97 1.2.12 0 .24-.01.37-.04.12-.03.24-.07.34-.11l.28 1.19c-.19.06-.4.12-.64.17-.23.05-.49.08-.76.08-.4 0-.74-.06-1.02-.18-.27-.13-.49-.3-.67-.52-.17-.21-.3-.48-.37-.78-.08-.3-.12-.64-.12-1.01zm4.36 2.17c0-.56.09-1.06.27-1.51s.41-.83.71-1.14c.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.37c.08.62.29 1.1.65 1.44.36.33.82.5 1.38.5.3 0 .58-.04.84-.13.25-.09.51-.21.76-.37l.54 1.01c-.32.21-.69.39-1.09.53s-.82.21-1.26.21c-.47 0-.92-.08-1.33-.25-.41-.16-.77-.4-1.08-.7-.3-.31-.54-.69-.72-1.13-.17-.44-.26-.95-.26-1.52zm4.61-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.08.45-.31.29-.5.73-.57 1.3zm3.01 2.23c.31.24.61.43.92.57.3.13.63.2.98.2.38 0 .65-.08.83-.23s.27-.35.27-.6c0-.14-.05-.26-.13-.37-.08-.1-.2-.2-.34-.28-.14-.09-.29-.16-.47-.23l-.53-.22c-.23-.09-.46-.18-.69-.3-.23-.11-.44-.24-.62-.4s-.33-.35-.45-.55c-.12-.21-.18-.46-.18-.75 0-.61.23-1.1.68-1.49.44-.38 1.06-.57 1.83-.57.48 0 .91.08 1.29.25s.71.36.99.57l-.74.98c-.24-.17-.49-.32-.73-.42-.25-.11-.51-.16-.78-.16-.35 0-.6.07-.76.21-.17.15-.25.33-.25.54 0 .14.04.26.12.36s.18.18.31.26c.14.07.29.14.46.21l.54.19c.23.09.47.18.7.29s.44.24.64.4c.19.16.34.35.46.58.11.23.17.5.17.82 0 .3-.06.58-.17.83-.12.26-.29.48-.51.68-.23.19-.51.34-.84.45-.34.11-.72.17-1.15.17-.48 0-.95-.09-1.41-.27-.46-.19-.86-.41-1.2-.68z" fill="#535353"/></g></svg>" /></a></div><div class="c-bibliographic-information__column"><h3 class="c-article__sub-heading" id="citeas">Cite this article</h3><p class="c-bibliographic-information__citation">Veltkamp, R., Purrucker, J.C. &amp; Weber, R. Neurovaskuläre Manifestationen von COVID‑19.
                    <i>Nervenarzt</i> <b>92, </b>531–539 (2021). https://doi.org/10.1007/s00115-021-01104-1</p><p class="c-bibliographic-information__download-citation u-hide-print"><a data-test="citation-link" data-track="click" data-track-action="download article citation" data-track-label="link" data-track-external="" href="https://citation-needed.springer.com/v2/references/10.1007/s00115-021-01104-1?format=refman&amp;flavour=citation">Download citation<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-download"></use></svg></a></p><ul class="c-bibliographic-information__list" data-test="publication-history"><li class="c-bibliographic-information__list-item"><p>Accepted<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2021-02-12">12 February 2021</time></span></p></li><li class="c-bibliographic-information__list-item"><p>Published<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2021-03-24">24 March 2021</time></span></p></li><li class="c-bibliographic-information__list-item"><p>Issue Date<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2021-06">June 2021</time></span></p></li><li class="c-bibliographic-information__list-item c-bibliographic-information__list-item--doi"><p><abbr title="Digital Object Identifier">DOI</abbr><span class="u-hide">: </span><span class="c-bibliographic-information__value"><a href="https://doi.org/10.1007/s00115-021-01104-1" data-track="click" data-track-action="view doi" data-track-label="link">https://doi.org/10.1007/s00115-021-01104-1</a></span></p></li></ul><div data-component="share-box"><div class="c-article-share-box u-display-none" hidden=""><h3 class="c-article__sub-heading">Share this article</h3><p class="c-article-share-box__description">Anyone you share the following link with will be able to read this content:</p><button class="js-get-share-url c-article-share-box__button" id="get-share-url" data-track="click" data-track-label="button" data-track-external="" data-track-action="get shareable link">Get shareable link</button><div class="js-no-share-url-container u-display-none" hidden=""><p class="js-c-article-share-box__no-sharelink-info c-article-share-box__no-sharelink-info">Sorry, a shareable link is not currently available for this article.</p></div><div class="js-share-url-container u-display-none" hidden=""><p class="js-share-url c-article-share-box__only-read-input" id="share-url" data-track="click" data-track-label="button" data-track-action="select share url"></p><button class="js-copy-share-url c-article-share-box__button--link-like" id="copy-share-url" data-track="click" data-track-label="button" data-track-action="copy share url" data-track-external="">Copy to clipboard</button></div><p class="js-c-article-share-box__additional-info c-article-share-box__additional-info">
                            Provided by the Springer Nature SharedIt content-sharing initiative
                        </p></div></div><h3 class="c-article__sub-heading">Schlüsselwörter</h3><ul class="c-article-subject-list"><li class="c-article-subject-list__subject"><span itemprop="about">SARS-CoV‑2</span></li><li class="c-article-subject-list__subject"><span itemprop="about">Zerebrale Ischämie</span></li><li class="c-article-subject-list__subject"><span itemprop="about">Intrazerebrale Blutung</span></li><li class="c-article-subject-list__subject"><span itemprop="about">Thrombolyse</span></li><li class="c-article-subject-list__subject"><span itemprop="about">Thrombektomie</span></li></ul><h3 class="c-article__sub-heading">Keywords</h3><ul class="c-article-subject-list"><li class="c-article-subject-list__subject"><span itemprop="about">SARS-CoV‑2</span></li><li class="c-article-subject-list__subject"><span itemprop="about">Cerebral ischemia</span></li><li class="c-article-subject-list__subject"><span itemprop="about">Intracerebral hemorrhage</span></li><li class="c-article-subject-list__subject"><span itemprop="about">Thrombolysis</span></li><li class="c-article-subject-list__subject"><span itemprop="about">Thrombectomy</span></li></ul><div data-component="article-info-list"></div></div></div></div></div></section>
                </div>
            </article>
        </main>

        <div class="c-article-extras u-text-sm u-hide-print" id="sidebar" data-container-type="reading-companion" data-track-component="reading companion">
            <aside>
                <div data-test="download-article-link-wrapper">
                    
    <div class="c-pdf-download u-clear-both">
        <a href="https://link.springer.com/content/pdf/10.1007/s00115-021-01104-1.pdf" class="c-pdf-download__link" data-article-pdf="true" data-readcube-pdf-url="true" data-test="pdf-link" data-draft-ignore="true" data-track="click" data-track-action="download pdf" data-track-label="button" data-track-external>
            
                <span>Download PDF</span>
                <svg aria-hidden="true" focusable="false" width="16" height="16" class="u-icon"><use xlink:href="#global-icon-download"/></svg>
            
        </a>
    </div>

                </div>

                <div data-test="collections">
                    
    

                </div>

                <div data-test="editorial-summary">
                    
                </div>

                <div class="c-reading-companion">
                    <div class="c-reading-companion__sticky" data-component="reading-companion-sticky" data-test="reading-companion-sticky">
                        

                        <div class="c-reading-companion__panel c-reading-companion__sections c-reading-companion__panel--active" id="tabpanel-sections">
                            <div class="u-mt-16" data-component-mpu>
    <aside class="c-ad c-ad--300x250">
        <div class="c-ad__inner">
            <p class="c-ad__label">Advertisement</p>
            <div id="div-gpt-ad-MPU1" data-pa11y-ignore data-gpt data-gpt-unitpath="/270604982/springerlink/115/article" data-gpt-sizes="300x250" data-gpt-targeting="pos=MPU1;articleid=s00115-021-01104-1;"></div>
        </div>
    </aside>
</div>

                        </div>
                        <div class="c-reading-companion__panel c-reading-companion__figures c-reading-companion__panel--full-width" id="tabpanel-figures"></div>
                        <div class="c-reading-companion__panel c-reading-companion__references c-reading-companion__panel--full-width" id="tabpanel-references"></div>
                    </div>
                </div>
            </aside>
        </div>
    </div>

    
    <script src="/.cdn-rum/performance.js" async></script>

    
        <script>
            
        </script>
    


        
    <footer class="app-footer" role="contentinfo" data-test="springerlink-footer">
        <div class="app-footer__aside-wrapper u-hide-print">
            <div class="app-footer__container">
                <p class="app-footer__strapline">Over 10 million scientific documents at your fingertips</p>
                
                    <div class="app-footer__edition" data-component="SV.EditionSwitcher">
                        <span class="u-visually-hidden" data-role="button-dropdown__title" data-btn-text="Switch between Academic & Corporate Edition">Switch Edition</span>
                        <ul class="app-footer-edition-list" data-role="button-dropdown__content" data-test="footer-edition-switcher-list">
                            <li class="selected">
                                <a data-test="footer-academic-link"
                                   href="/siteEdition/link"
                                   id="siteedition-academic-link">Academic Edition</a>
                            </li>
                            <li>
                                <a data-test="footer-corporate-link"
                                   href="/siteEdition/rd"
                                   id="siteedition-corporate-link">Corporate Edition</a>
                            </li>
                        </ul>
                    </div>
                
            </div>
        </div>
        <div class="app-footer__container">
            <ul class="app-footer__nav u-hide-print">
                <li><a href="/">Home</a></li>
                <li><a href="/impressum">Impressum</a></li>
                <li><a href="/termsandconditions">Legal information</a></li>
                <li><a href="/privacystatement">Privacy statement</a></li>
                <li><a href="https://www.springernature.com/ccpa">California Privacy Statement</a></li>
                <li><a href="/cookiepolicy">How we use cookies</a></li>
                
                <li><a class="optanon-toggle-display" href="javascript:void(0);">Manage cookies/Do not sell my data</a></li>
                
                <li><a href="/accessibility">Accessibility</a></li>
                <li><a id="contactus-footer-link" href="/contactus">Contact us</a></li>
            </ul>
            <div class="c-user-metadata">
    
        <p class="c-user-metadata__item">
            <span data-test="footer-user-login-status">Not logged in</span>
            <span data-test="footer-user-ip"> - 78.54.4.35</span>
        </p>
        <p class="c-user-metadata__item" data-test="footer-business-partners">
            Not affiliated
        </p>

    
</div>

            <a class="app-footer__parent-logo" target="_blank" rel="noopener" href="//www.springernature.com"  title="Go to Springer Nature">
                <span class="u-visually-hidden">Springer Nature</span>
                <svg width="125" height="12" focusable="false" aria-hidden="true">
                    <image width="125" height="12" alt="Springer Nature logo"
                           src=/oscar-static/images/springerlink/png/springernature-60a72a849b.png
                           xmlns:xlink="http://www.w3.org/1999/xlink"
                           xlink:href=/oscar-static/images/springerlink/svg/springernature-ecf01c77dd.svg>
                    </image>
                </svg>
            </a>
            <p class="app-footer__copyright">&copy; 2021 Springer Nature Switzerland AG. Part of <a target="_blank" rel="noopener" href="//www.springernature.com">Springer Nature</a>.</p>
            
        </div>
        
    <svg class="u-hide hide">
        <symbol id="global-icon-chevron-right" viewBox="0 0 16 16">
            <path d="M7.782 7L5.3 4.518c-.393-.392-.4-1.022-.02-1.403a1.001 1.001 0 011.417 0l4.176 4.177a1.001 1.001 0 010 1.416l-4.176 4.177a.991.991 0 01-1.4.016 1 1 0 01.003-1.42L7.782 9l1.013-.998z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="global-icon-download" viewBox="0 0 16 16">
            <path d="M2 14c0-.556.449-1 1.002-1h9.996a.999.999 0 110 2H3.002A1.006 1.006 0 012 14zM9 2v6.8l2.482-2.482c.392-.392 1.022-.4 1.403-.02a1.001 1.001 0 010 1.417l-4.177 4.177a1.001 1.001 0 01-1.416 0L3.115 7.715a.991.991 0 01-.016-1.4 1 1 0 011.42.003L7 8.8V2c0-.55.444-.996 1-.996.552 0 1 .445 1 .996z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="global-icon-email" viewBox="0 0 18 18">
            <path d="M1.995 2h14.01A2 2 0 0118 4.006v9.988A2 2 0 0116.005 16H1.995A2 2 0 010 13.994V4.006A2 2 0 011.995 2zM1 13.994A1 1 0 001.995 15h14.01A1 1 0 0017 13.994V4.006A1 1 0 0016.005 3H1.995A1 1 0 001 4.006zM9 11L2 7V5.557l7 4 7-4V7z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="global-icon-institution" viewBox="0 0 18 18">
            <path d="M14 8a1 1 0 011 1v6h1.5a.5.5 0 01.5.5v.5h.5a.5.5 0 01.5.5V18H0v-1.5a.5.5 0 01.5-.5H1v-.5a.5.5 0 01.5-.5H3V9a1 1 0 112 0v6h8V9a1 1 0 011-1zM6 8l2 1v4l-2 1zm6 0v6l-2-1V9zM9.573.401l7.036 4.925A.92.92 0 0116.081 7H1.92a.92.92 0 01-.528-1.674L8.427.401a1 1 0 011.146 0zM9 2.441L5.345 5h7.31z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="global-icon-search" viewBox="0 0 22 22">
            <path fill-rule="evenodd" d="M21.697 20.261a1.028 1.028 0 01.01 1.448 1.034 1.034 0 01-1.448-.01l-4.267-4.267A9.812 9.811 0 010 9.812a9.812 9.811 0 1117.43 6.182zM9.812 18.222A8.41 8.41 0 109.81 1.403a8.41 8.41 0 000 16.82z"/>
        </symbol>
        <symbol id="icon-info" viewBox="0 0 18 18">
            <path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm0 7h-1.5l-.11662113.00672773c-.49733868.05776511-.88337887.48043643-.88337887.99327227 0 .47338693.32893365.86994729.77070917.97358929l.1126697.01968298.11662113.00672773h.5v3h-.5l-.11662113.0067277c-.42082504.0488782-.76196299.3590206-.85696816.7639815l-.01968298.1126697-.00672773.1166211.00672773.1166211c.04887817.4208251.35902055.761963.76398144.8569682l.1126697.019683.11662113.0067277h3l.1166211-.0067277c.4973387-.0577651.8833789-.4804365.8833789-.9932723 0-.4733869-.3289337-.8699473-.7707092-.9735893l-.1126697-.019683-.1166211-.0067277h-.5v-4l-.00672773-.11662113c-.04887817-.42082504-.35902055-.76196299-.76398144-.85696816l-.1126697-.01968298zm0-3.25c-.69035594 0-1.25.55964406-1.25 1.25s.55964406 1.25 1.25 1.25 1.25-.55964406 1.25-1.25-.55964406-1.25-1.25-1.25z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="icon-success" viewBox="0 0 18 18">
            <path d="M9 0a9 9 0 110 18A9 9 0 019 0zm3.486 4.982l-4.718 5.506L5.14 8.465a.991.991 0 00-1.423.133 1.06 1.06 0 00.13 1.463l3.407 2.733a1 1 0 001.387-.133l5.385-6.334a1.06 1.06 0 00-.116-1.464.991.991 0 00-1.424.119z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="icon-chevron-down" viewBox="0 0 16 16">
            <path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule="evenodd" transform="matrix(0 1 -1 0 11 1)"/>
        </symbol>
    </svg>

    </footer>



    </div>
    
    
</body>
</html>
